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ABSTRACT 
SENECAVIRUS A: EPIDEMIOLOGY, PATHOGENESIS AND INFECTION 
DYNAMICS 
LOK RAJ JOSHI 
2017 
Senecavirus A (SVA) is a positive sense single-stranded virus that belongs to the genus 
Senecavirus within the family Picornaviridae. Senecavirus has been present in US swine 
population since 1988. However, there have been only a few reports of SVA associated 
with disease in last two decades. In late 2014 early 2015, a sudden increase in the number 
of cases of Senecavirus A associated with vesicular disease was observed in Brazil, the US 
and China. Affected pigs presented vesicles on snout, coronary band, and dewclaw. 
Additionaly, increased neonatal mortality has been reported in the field. Many aspects of 
SVA epidemiology, infection biology, and pathogenesis, remain unknown. Also, the 
cause(s) for the recent emergence of SVA in swine remains unknown. The objectives of 
our study were – 1) To investigate epidemiological factors that may contribute to SVA 
spread in the field and 2) To assess the pathogenesis and infection dynamics of SVA in 
finishing pigs. In our first study, a diagnostic investigation was conducted in swine herds 
affected by vesicular disease and neonatal mortality. SVA was detected and isolated from 
vesicular lesions and tissues of affected pigs, from environmental samples collected in 
affected and non-affected control farms. Among the environmental samples SVA was 
consistently detected in mouse feces and in a small intestine sample collected in one 
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affected farm. Additionally, SVA RNA was detected in houseflies collected from both 
affected and unaffected farms. Whole genome sequence of the SVA isolated from the 
clinical and environmental samples was determined and phylogenetic analysis was 
performed. This analysis revealed that all the contemporary SVA isolates (obtained during 
2014-2015) cluster together in a phylogenetic tree. However, a significant difference was 
found between contemporary and historical isolates of SVA and they form separate clades 
in the phylogenetic tree. On our second study, finishing pigs were experimentally infected 
with SVA SD15-26 strain to determine pathogenesis and infection dynamics of SVA. SVA 
inoculated animals showed vesicular lesions on the snout and feet by four days of infection. 
Infected animals presented clinical signs described in field outbreaks, including lethargy, 
lameness and anorexia. Additionally, SVA infected animals shed virus in feces, oral and 
nasal secretions and viable virus was isolated from oral fluid for up to 21 days post-
inoculation (pi). SVA RNA was detected in multiple tissues during the acute stage of 
infection, while it was detected in the tonsil of all infected animals up to day 38 pi. SVA 
inoculated animals developed an early and robust neutralizing antibody response against 
the virus. Neutralizing antibodies were first detected on day 5 pi. Infected animals recover 
within 2 weeks of infection. These studies provide significant insights the epidemiology, 
pathogenesis and infection dynamics of Senecavirus A infection in pigs. 
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Chapter 1: Literature Review 
Senecavirus A  
Senecavirus A (SVA), formerly known as Seneca Valley virus, is the single species 
of the genus Senecavirus within the family Picornaviridae [1]. SVA is a single-stranded 
positive-sense RNA virus with a genome of approximately 7.2 kb in length [1]. SVA was 
first isolated in the United States in 2002 as a cell culture contaminant [2, 3]; however, 
sequencing of archived picorna-like viruses isolated from pigs with various clinical 
manifestations revealed the presence of SVA in the U.S. swine population since 1988 [2, 
4]. The complete genome sequence of SVA strain SVV-001 was first described by 
Knowles et al. [5]. Based on the complete genome sequence,  SVV-001 was found closely 
related to members of the genus Cardiovirus, whilst a significant proportion of its genome 
still differs from other picornaviruses [1]. Thus, a new genus Senecavirus within the family 
Picornaviridae was created to include Seneca Valley virus, which was renamed to 
Senecavirus A in 2014 [6].  
Virus Structure and Genome  
 SVA is a small non-enveloped virus having a size of 27 nm in diameter. The virus 
has an icosahedral capsid composed of four subunits: VP1, VP2, VP3, and VP4. Out of 
four subunits, VP1, VP2, VP3 are located on the outer surface of the virus particles whereas 
VP4 is located on the internal side of the capsid  [7]. The single-stranded RNA genome is 
enclosed within the icosahedral capsid which is about 7.2 kb in length. Complete genome 
sequence of the SVA isolate SVV-001 was determined by Hales et al. [1]. The genome of 
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SVA contains a unique open reading frame which encodes a large polyprotein of 2,181 
amino acids [1].  
The genome contains a 5’ untranslated region (UTR)  of about 666 nucleotides and a 
shorter 3’ UTR of 71 nucleotides. The 5’ UTR of the SVA contains a secondary structure 
named internal ribosomal entry site (IRES) [1, 8].  This structure is important for the cap-
independent translation of viral mRNA of picornaviruses [9]. Additionally, two stem-loop 
structures are formed due to the folding of 3’ UTR of the SVA RNA genome[1].  
The single open reading frame (ORF) encodes a large polyprotein which is cleaved 
to produce 12 mature proteins (5’UTR-L-1A-1B-1C-1D-2A-2B-2C-3A-3B-3C-3D- 
3’UTR-poly A tail). The leader protein (L) is known to play a role in blocking host-cell 
protein synthesis in some picornaviruses like foot-and-mouth disease virus (FMDV) [10]. 
But, the function of SVA leader protein is not completely understood as its sequence differs 
from the leader protein of other viruses. The P1 polypeptide is cleaved into VP0, VP3 and 
VP1 by the 3C protease. VP0 undergoes further cleavage during maturation to produce 
VP2 and VP4. SVA 2A protein has been predicted to perform the ribosome-skipping 
function as in aphthoviruses and erboviruses. The SVA 2B has a similar secondary 
structure to the 2B of other picornaviruses and has been predicted to act as viroporins. The 
2C protein plays a role in RNA synthesis. The function of 3A protein is not completely 
understood. The 3B region encodes VPg which is linked to the 5’ end of the virus genome. 
Like other picornaviruses 3C protein of SVA has proteolytic activity and is responsible for 
cleavage of the viral polyprotein. The 3D polypeptide is a major component of RNA-
dependent RNA polymerase and actively participates in virus replication [1]. Although 
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SVA is very closely related to the cardiovirus, these two viruses differ greatly in the 2A 
and 3A region [1]. 
Senecavirus A and its association to vesicular disease 
SVA is has been associated with vesicular disease in swine. The lesions caused by 
SVA are similar to those caused by other reportable vesicular disease causing agents of 
swine, including FMDV, swine vesicular disease virus (SVDV), vesicular stomatitis virus 
(VSV), and swine vesicular exanthema virus (SVEV). Before the identification of 
Senecavirus A, any vesicular disease of swine diagnosed negative to the aforementioned 
vesicular disease viruses were considered Swine Idiopathic Vesicular Disease (SIVD). 
Swine idiopathic vesicular disease has been reported in Australia [11], New Zealand [12], 
Canada [13] and the United States  [4, 14, 15]. Earlier cases were suspected to be caused 
by feed toxicity. Munday and Ryan [11] suggested the association between the vesicular 
disease and feeding of marine feed products. SVID  reported in New Zealand was linked 
to the contact of pigs with green vegetable material containing parsnip (Pastinaca sativa) 
or celery (Apium graveolens ), followed by exposure to periods of extended sunshine [12]. 
In addition,  the lesions associated with SIVD have been also linked to other pathogens like 
parvovirus [16, 17] and porcine enterovirus group III [18]. Amass et al. [4] detected porcine 
enterovirus in the coronary band lesions in pigs and seroconversion to parvovirus during 
SIVD outbreak in Indiana.  
Association of SVA with SIVD  was first described by Pasma et al. [13] in hogs 
that arrived at a harvest facility in Minnesota from Manitoba. Senecavirus A was detected 
in affected pigs by polymerase chain reaction (PCR). Animals presented ruptured necrotic 
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vesicles on the snout and coronary bands and some of them showed signs of lameness. A 
few years later, Singh et al. [15] detected SVA in  vesicular scrappings and oro-pharyngeal 
fluid collected from a boar affected by the vesicular disease by using real-time RT-PCR. 
Since other pathogens (enterovirus, parvovirus) were also isolated from cases of 
SIVD, the actual role of SVA on the development of the disease was not clear. Specially 
because several attempts to fulfill the Koch’s postulates failed to reproduce the disease in 
pigs Knowles et al. [5] for example, infected pigs with two different isolates of SVA, 
however, infected pigs did not develop any specific disease. Another attempt to reproduce 
the disease in pigs by Yang et al.  [19]was also not successful. Notably, a very high titer (5 
Ⅹ 1011 SVA virus particles/pig) was used in some of the pigs in their experiment and were 
infected using the both coronary band and intralingual route.  
Notably, disease was first reproduced by Montiel et al. [20] showing the causal 
relation between the SVA and vesicular disease. In this work, the authors  were able to 
induce vesicular lesions in 9-week old pigs inoculated via the intranasal route. Despite the 
link between SVA and vesicular disease several aspects of SVA infection biology and 
pathogenesis were still unknown. Therefore, we performed a study to assess the 
pathogenesis of SVA in finishing pigs. In this study, inoculation of finishing pigs with SVA 
resulted in clinical signs (lethargy and lamenss) and lesions (vesicles on the snout and feet) 
that were consistent with descriptions of field cases of SVA. A complete description of our 
findings can be found on Chapter 3 of this thesis. The study by Montiel and collaborators 
and ours provide evidence that SVA can cause vesicular disease in swine. It is noteworthy 
to mention that both studies used contemporary isolates of SVA. 
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Vesicles on the snout, oral mucosa, hoofs and coronary bands are the characteristic 
lesions of  SVA infection in pigs [21-25]. These vesicles usually range from 1-3 cm in 
diameter and eventually ruptured leaving a dry scab in the affected skin [25]. Affected pigs 
may also show small erythematous areas on the snout and feet without developing classical 
vesicular lesions [26]. Affected pigs show lameness, lethargy, and anorexia [21, 26]. There 
is no significant changes in body temperature [22, 26].  
In addition to vesicular disease, SVA has also been associated with neonatal 
mortality in pigs. Several reports describe a sudden increase in mortality of piglets with 
less than 7 days of age [23]. Mortality rates range between 30-70%. Piglets show signs of 
diarrhea, ill thrift, anorexia, lethargy and sometimes neurological signs [22, 23, 25]. Piglets 
older than a week are not affected clinically. Affected piglets do not reveal any gross or 
histopathological lesions, whereas SVA can be detected in serum and tissues of affected 
animals including the brain, spleen, heart, kidney, small intestine, and colon. Despite the 
association with neonatal mortality in the field the actual role of SVA for this clinical 
manifestation is not completely understood. 
Re-emergence of Senecavirus A  
Although Senecavirus A has been present in the US swine population since 1988, 
only sporadic cases of swine idiopathic vesicular disease (SIVD) were reported in the last 
two decades. Notably a sudden increase in the incidence of SVA associated with vesicular 
disease in pigs was been observed in 2014-2015 . In late 2014, outbreaks of SVA were 
reported in Brazil [21]. Several other outbreaks of SVA in Brazil were reported within a 
few months. It has been estimated that about 80% of the farms were affected in Brazil [21, 
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22]. In the summer of 2015, SVA was reported in the United States [27]. Since then there 
were more than 200 cases of SVA confirmed in the USA  . These cases have been mostly 
reported in the Midwest region of USA including Iowa, Nebraska, Minnesota, Illinois, 
Missouri, South Dakota [28-30]. SVA associated vesicular disease and neonatal mortality 
has also been reported in China  [24, 31].  
 The reason for the recent surge of SVA outbreaks is still unknown. High incidence 
in Brazil is assumed to be due to the exposure of SVA to the naïve pig population [22]. 
However, the virus has been present in US swine population since 1988, and still, a 
significant rise in the number of outbreaks was observed.. Genetic evolution of SVA might 
have contributed to the increased pathogenicity of SVA. Genetic comparisons between 
historical isolates (obtained between 1988-2002) and recent SVA isolates (obtained 
between 2007-2015) revealed a high genetic diversity between the virus [25]. All the 
contemporary isolates obtained in the US, Brazil and China are about 96% to 99% identical 
to each other, whereas there is about 10% difference between the historical and 
contemporary isolates [22, 25]. So, these genetic changes might have resulted in increased 
pathogenicity of SVA either by increasing adaptation of SVA in pigs or by improving its 
ability to spread between hosts [25, 32]. 
Host range and transmission of SVA 
Pigs are considered the natural host for the SVA. Neutralizing antibodies have been 
detected in both SVA affected and disease-free pigs [5]. Neutralizing antibodies to SVA 
has also been detected in cattle and mice. This suggests that other animal species could be 
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the potential hosts of SVA [5]. No neutralizing antibodies were detected when four 
different species of primates were tested.  
 The routes of SVA transmission have not been well established. The FMDV, a 
related picornavirus that causes similar disease is transmitted through the direct contact of 
infected animals, contaminated objects and/or by inhalation of aerosolized viral particles. 
FMDV infected animals shed the virus through all their body secretions and excretions  
[33]. It is not known whether the same is true for SVA. Though it has been shown that 
SVA infected animals can shed the virus through fecal, oral and nasal routes. The virus can 
be detected in the oral fluid up to 4 weeks pi and viable virus has been detected in oral fluid 
for up to 3 weeks pi [26, 29]. Additionally, rodents and/or houseflies may also play a role 
on SVA epidemiology. Viable virus has been isolated from the mice collected from SVA 
infected farm. Also, SVA nucleic acid has been detected from the flies collected from 
disease free farm, suggesting that these pests may play a role in SVA ecology [25]. 
Host immune response to SVA infection  
Humoral immune response plays an important role on clearance of picornaviruses 
from infected animals. In our pathogenesis study (Chapter 3) we have shown that 
neutralizing antibodies are produced at very early stage of SVA infection. Robust 
neutralizing antibody levels can be seen within 5 days of infection [26, 34]. Neutralizing 
antibody titers peak around day 14 pi. Notably, increased levels of NA correlate with 
disease resolution and clearance of the virus from tissues and body excretions/secretions. 
The role and importance of the cellular immunity to SVA remain unknown. Chen et al. 
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[34] demonstrated only a minimal level of IFN-alpha production by day 3 post infection, 
while IFN-gamma was undetectable on SVA infected animals.   
Diagnosis  
Reverse transcription polymerase chain reaction (RT-PCR) has been widely used 
for the detection of viral nucleic acid. Primers targeting the VP1 region or the 3D 
polymerase gene have been used successfully for the diagnosis of SVA [5, 21, 25, 35]. 
SVA RNA is detectable in vesicular fluid, lesion scrapping, oral and nasal fluids and organs 
including tonsil and spleen [26, 35]. SVA-specific monoclonal antibodies have been 
developed which can be used for competitive enzyme-linked immunosorbent assay 
(cELISA) and immunohistochemistry assay (IHC) [19]. These monoclonal antibodies do 
not cross-react with other vesicular disease virus [19].  
 Virus isolation has been successfully performed by many laboratories. Notably, the 
virus was first isolated as a contaminant of human retinoblast (PER.C6) cells [1]. Human 
lung cancer cell monolayers (NCI-H1299) are highly permissive to SVA replication and 
have been successfully used for isolation and amplification of SVA [19, 30]. Virus isolation 
has also been performed on swine testis (ST) cells [19], and baby hamster kidney (BHK-
21) cells [31]. Virus neutralization test, immunofluorescence assay, and ELISA can be 
performed to measure the serological response [26]. Indirect ELISA using VP2 protein has 
been shown to detect antibodies in serum collected from pigs at different stages of infection 
[36]. 
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Prevention and control 
 Since there is very little information available about SVA transmission and 
pathogenesis some of the methods that have already being used to control other 
picornaviruses like FMDV can be used for SVA control. Use of disinfectants like sodium 
hydroxide, 0.2% citric acid, sodium hypochlorite can be effective as they have been proved 
to be effective against FMDV [30]. Strong biosecurity measures should be applied on 
farms. Since rodents and flies could play a role on the epidemiology and rodents have been 
shown to carry live SVA, measures to control these pests should be considered in order to 
minimize the potential risk of SVA spread. Currently, there are no vaccines available for 
SVA, thus continued surveillance and rapid diagnosis is essential to control SVA. 
Objectives  
The overall goal of our study was to improve the understanding of SVA epidemiology and 
pathogenesis. The objectives of our study were: 
Objective 1: To assess factors that could play a role on SVA ecology during an outbreak 
in the field 
 To achieve this objective an outbreak investigation was carried in SVA affected 
swine farms. Various clinical and environmental samples were collected to assess the 
presence of SVA. Among those samples houseflies and mice were collected to investigate 
their potential involvement on SVA epidemiology. The results of this study are presented 
in Chapter 2 of this thesis.  
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Objective 2: To determine the pathogenesis and infection dynamics of SVA in finishing 
pigs. 
To achieve this objective an experimental infection was performed in pigs. Clinical 
signs, viral shedding, virus tissue distribution and humoral response was assessed on 
infected pigs. The results of this study are presented in Chapter 3 of this thesis. 
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Chapter 2 
Detection of the Emerging Senecavirus A in Pigs, Mice and Houseflies 
Lok R. Joshi1, Kristin A. Mohr1, Travis Clement1, Kyle S. Hain1, Bryan Myers2, Joseph 
Yaros2, Eric A. Nelson1, Jane Christopher-Hennings1, Danielle Gava3, Rejane Schaefer3, 
Luizinho Caron3, Scott Dee2, Diego G. Diel1# 
 
1Animal Disease Research and Diagnostic Laboratory, Department of Veterinary and 
Biomedical Sciences, South Dakota State University, Brookings, 57007, SD, USA. 
2Pipestone Applied Research, Pipestone Veterinary Services, Pipestone, MN, USA 
3Embrapa Swine and Poultry, Concórdia, SC, Brazil. 
 
Running title: Detection of SVA in pigs, mice and houseflies.  
#Address correspondence to Diego G. Diel, diego.diel@sdstate.edu. 
 
Published on Journal of Clinical Microbiology, 54:1536 –1545 – Published online on 
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ABSTRACT 
 Senecavirus A (SVA) is an emerging picornavirus that has been recently associated 
with increased outbreaks of vesicular disease and neonatal mortality in swine. Many 
aspects of SVA infection biology and epidemiology remain unknown. Here, we present a 
diagnostic investigation conducted in swine herds affected by vesicular disease and 
increased neonatal mortality. Clinical and environmental samples were collected from 
affected and unaffected herds and screened for the presence of SVA by real-time PCR and 
virus isolation. Notably, SVA was detected and isolated from vesicular lesions and tissues 
from affected pigs, environmental samples, mouse feces, and mouse small intestine. SVA 
nucleic acid was also detected in houseflies collected in affected farms and in a farm with 
no history of vesicular disease. Detection of SVA in mice and housefly samples and 
recovery of viable virus from mouse feces and small intestine here, suggests that these 
pests may play a role on the epidemiology of SVA. These results provide important 
information that may allow the development of improved prevention and control strategies 
for SVA. 
Key words: Senecavirus A, SVA, Seneca Valley virus, epidemiology. 
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Introduction 
Senecavirus A (SVA) is a single-stranded positive sense RNA virus of the genus 
Senecavirus, family Picornaviridae [1]. The SVA genome is ~7.2 kb in length and contains 
a unique open reading frame encoding a large polyprotein (2,181 aa) which is cleaved to 
produce twelve mature proteins (5’-L-1A-1B-1C-1D-2A-2B-2C-3A-3B-3C-3D-3’) [1]. 
Among the picornaviruses, SVA is more closely related to members of the genus 
Cardiovirus [1], including the encephalomyocarditis virus (ECMV) and Theiloviruses 
which are known to infect a wide range of vertebrate animals including pigs, mice, and 
humans [37].   
Senecavirus A was originally identified as a cell culture contaminant in the US in 
2002[1, 5]; however, subsequent sequencing of picorna-like viruses isolated from pigs 
revealed the presence of the virus in the US swine population since 1988 [4, 5, 15]. In the 
past ten years, sporadic reports have described the association of SVA with cases of swine 
idiopathic vesicular disease (SIVD) in Canada and in the US [4, 5, 13, 15]. Notably, since 
November 2014 several reports of SVA associated with vesicular disease in swine have 
been described in Brazil, and since July 2015 an increased number of cases of SVA 
associated with vesicular lesions and neonatal mortality in swine have been reported in the 
US [21, 22, 38, 39].  
Characteristic lesions associated with SVA infection in pigs include vesicles on the 
snout, oral mucosa, hoofs, and coronary bands, and typical clinical signs include lameness, 
lethargy, anorexia and fever [4, 13, 15, 21, 22]. Recently, SVA has also been associated 
with increased mortality (30-70%) in piglets less than seven days of age [22]. In these 
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cases, SVA has been detected in serum and multiple tissues of affected piglets, including 
brain, spleen, liver, heart, kidney, small intestine, and colon; however, no pathological 
changes have been observed in SVA positive tissues [39]. 
Many aspects of SVA infection biology, pathogenesis and epidemiology remain 
unknown, including the origin of the virus, its natural reservoirs and transmission pathways 
[40]. Notably, a serologic survey conducted in the US, demonstrated neutralizing 
antibodies against SVA in swine, cattle and mice [5], suggesting a potential role for these 
species in the epidemiology of the virus. To date, however, SVA (live virus and/or nucleic 
acid) has been detected only in pigs and the actual contribution of other species for the 
virus ecology is still unknown.  
Here, we present the results of a diagnostic investigation conducted in swine herds 
affected by vesicular disease and neonatal mortality in the US and in Brazil. By using real-
time PCR (rRT-PCR) screening followed by virus isolation in cell culture, we detected 
SVA in clinical and environmental samples, including environmental swabs, mouse feces, 
and mouse small intestine. SVA nucleic acid was also detected in whole fly homogenates. 
Detection of SVA in mice and houseflies and isolation of the virus from mice suggest that 
these pests may play a role on SVA epidemiology.  
Materials and Methods 
Characteristics of target swine herds. A diagnostic investigation was conducted in swine 
herds located in the Midwest and Southern regions of the US and Brazil, respectively. The 
US case herd (herd A) is a 2800 sow farrow-to-wean commercial farm located in a high 
swine density area of south-central Minnesota. Mouse and fly samples were also collected 
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from an unaffected farm (absence of vesicular disease; herd B) located at approximately 
0.3 kilometers from herd A. Herd B consists of a 5400 sow farm divided into a 4000 sow 
farrow-to-wean herd and a 1400 sow gilt developer unit (GDU). These farms contain air 
filtration systems to minimize the risk of introduction of air borne pathogens.  
 Case herds C and D are small farrow-to-finish research farms (518 and 843 animals, 
respectively) that belong to the Brazilian Agricultural Research Corporation (Embrapa 
Swine and Poultry) and are located in Western Santa Catarina, Brazil. Case herd D is 
located at approximately 0.2 km from case herd C. Samples were also collected from an 
unaffected farrow-to-finish farm (absence of vesicular disease; herd E; 179 animals) 
located at approximately 0.2 km from case herds C and D. It is important to note that the 
farms sampled in our study have closed herds and no external animals had been introduced 
to their herds for at least six months preceding the vesicular disease outbreaks. 
Diagnostic investigation. A diagnostic investigation was conducted in case herds A, C 
and D two-to-three days after the onset of the vesicular disease outbreaks. Clinical samples 
collected from case herd A included oral swabs, vesicular fluids, serum, and whole piglets. 
These samples were submitted to the University of Minnesota Veterinary Diagnostic 
Laboratory (UMN VDL), and referred to the Foreign Animal Disease Diagnostic 
Laboratory at the Plum Island Animal Disease Center for foreign animal disease 
investigation. Oral swabs and tissue samples were subjected to rRT-PCR for Senecavirus 
A and other vesicular diseases of swine, including Foot-and-mouth disease virus (FMDV), 
Vesicular stomatitis virus (VSV), Swine vesicular disease (SVD) and Vesicular Exanthema 
of Swine (VES). Tissue samples collected from piglets including small and large intestine 
pools were subjected to rRT-PCR assays. 
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 Clinical samples from case herds C and D including vesicular fluid, nasal swabs, 
skin from ruptured vesicles, intestine and tonsil were subjected to conventional RT-PCR 
for SVA at Embrapa. At necropsy, a complete pathological examination was conducted in 
affected piglets. The diagnostic investigation at Embrapa was conducted under the 
supervision of Cidasc (Company of integrated agricultural development of Santa 
Catarina), the State’s official agricultural inspection agency. 
Environmental specimen collection and processing. Multiple environmental samples 
were collected from affected herd A following the diagnostic confirmation of SVA (Table 
2). Samples were collected from the interior and exterior premises of herd A (Table 2). 
Interior samples included lesion swabs, 2 mL aliquots of injectable veterinary products 
(antibiotics, anti-inflammatory, etc), swabs from surfaces of walkways, personnel entry 
swabs, aliquots of semen, flies, whole mice, mouse feces and interior surface swabs of 
rodent bait boxes. Exterior samples included dust from exhaust fans, concrete pads and 
walkways, swabs of interior surfaces of feed bins, whole mice, interior surface swabs of 
bait boxes and mice feces, equipment swabs and flies. Since several mouse and fly samples 
collected from herd A tested positive for SVA nucleic acid, these samples were collected 
from an unaffected herd B. Additionally, a few mouse and fly samples were also collected 
from SVA affected (C and D) and unaffected herds (E) in Brazil.  
Paint rollers were used to sample all interior and exterior surfaces and equipment, 
collecting dust from the exterior shutters of exhaust fans and sample feed bins. Insects were 
collected using sticky traps and jug traps (Wellmark International, Schaumberg, IL, USA) 
and whole fly homogenates processed as previously described [37]. Mouse fecal samples 
were removed from bait boxes using phosphate buffered saline (PBS) moistened Dacron 
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swabs and stored in sterile conical tubes containing 3 mL of PBS (Fisher Scientific, 
Hanover Park, IL, USA). Similar methods were used to collect interior surface samples 
from bait boxes and the hands and soles of footwear of incoming personnel [5]. Mice were 
dissected under a biosafety cabinet and tissues (small intestine, heart, lung, brain, liver 
spleen and kidneys) collected using standard aseptic technique. All external samples were 
collected in the immediate perimeter (within 5 m) of affected or unaffected farm barns.  
RNA extraction and real-time PCR. Viral nucleic acid was extracted using the MagMAX 
viral RNA/DNA isolation kit (Life Technologies, Carlsbad, CA) following the 
manufacturer’s instructions. Detection of SVA RNA was performed using a commercial 
real-time PCR kit targeting the SVA 3D polymerase gene (EZ-SVA, Tetracore Inc., 
Rockville, MD) or a conventional RT-PCR with primers targeting a region of the SVA 
VP1-VP3 genes [5]. All real-time PCR screenings on environmental samples from herds 
A and B were performed at the SDSU Animal Disease and Research Diagnostic Laboratory 
(ADRDL). 
 Conventional RT-PCR was performed using SVA specific primers (SVV-1C556F 
and SVV-1D441R (3)) and the High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystem, Carlsbad, CA) following the manufacturer’s instructions. PCR amplicons were 
subjected to electrophoresis in 1% agarose gels and analyzed under a UV transilluminator.   
Virus isolation. Virus isolation was performed in NCI-H1299 non-small cell lung 
carcinoma cell lines (ATCC CRL-5803). All samples were processed in PBS (10% v/w). 
After homogenization samples were cleared by centrifugation at 1,200 rpm at 4oC. The 
supernatant was diluted (1:1) in RPMI 1640 medium supplemented with penicillin (300 
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U/mL), streptomycin (300 µg/mL) and amphotericin B (7.5 µg/mL), filtered (0.45 µm) and 
inoculated into semi-confluent (60-80%) monolayers of NCI-H1299 cells cultured in 24 
well plates. After 1 h adsorption, 1 mL complete growth medium (RPMI 1640, 10% fetal 
bovine serum, 4 mM L-glutamine, penicillin [100 U/mL], spreptomycin [100 µg/mL] and 
amphotericin B [2.5 µg/mL]) was added to each well, and cells were incubated at 37oC 
with 5% CO2 for five days. Each sample was inoculated in duplicate wells and cell 
monolayers were monitored daily for cytopathic effect (CPE). Samples were subjected to 
five blind passages and those samples that did not induce CPE in inoculated monolayers 
after the fifth passage were considered negative. Mock-inoculated control cells were 
included as negative controls on each passage. Isolation of SVA was confirmed by rRT-
PCR and immunofluorescence assays.  
Immunofluorescence. Indirect immunofluorescence was used to confirm isolation of 
SVA. Infected cell cultures showing CPE were fixed with 3.7% formaldehyde for 30 min 
at room temperature, washed three times with PBS and permeabilized with 0.2% Triton-
X100-PBS for 10 min at RT. After permeabilization, cells were washed three times with 
PBS and incubated with SVA specific monoclonal antibody (F61 SVV-9-2-1) (13) or 
swine convalescent serum. After primary antibody incubation, cells were washed as above 
and incubated with anti-mouse- (Alexa Fluor® 488; Life Technologies, Carlsbad, CA) or 
anti-swine-IgG (DyLight® 488; Bethyl Laboratories, Montgomery, TX) secondary 
antibodies, respectively.  
SVA genome sequencing. The complete genome sequence of select Senecavirus A 
isolates obtained in this study were determined by using a primer walking RT-PCR 
sequencing approach. For this, nine sets of overlapping primers (F1 to F9) covering the 
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entire SVA genome were designed (primer sequences available upon request) using the 
PRIMO primer design software [41]. Viral cDNA was synthesized using the ProtoScript II 
reverse transcriptase (New England Biolabs,  Ipswich, MA) and a mixture of oligo d(T)18 
and random primer 6 (NEB, Ipswich, MA). Two microliters of cDNA were used in PCR 
amplification reactions with the Q5® Hot Start High-Fidelity 2X Master Mix (NEB, 
Ipswich, MA) following to the manufacturer’s protocols. The PCR amplicons (F1 to F9) 
were subjected to electrophoresis in 1% agarose gels to confirm correct target amplification 
and purified by using the GenJet PCR purification kit (Thermo Fisher Scientific, Waltham, 
MA). Purified PCR products were sequenced with fluorescent dideoxynucleotide 
terminators in an ABI 3700 automated sequencer (Applied Biosystems Inc., Foster City, 
CA). Sequence assembly and editing were performed with the LaserGene analysis software 
package (LaserGene, version 5.07; DNAStar Inc., Madison, WI).  
SVA genome comparison and phylogenetic analysis. Alignment and comparison of the 
complete genome and VP1 nucleotide sequences between SVA isolates obtained here and 
those of SVA strains available on GenBank (Accession numbers, DQ641257, KC667560, 
KR063108, KR063107, KR063109, KT757280, KT757281, KT757282, KT321458, 
KR075677, KR075678, EU271758, EU271763, EU271757, EU271762, EU271761, 
EU271760, EU271759) were performed by using ClustalW [42] in the MEGA 6 software 
[43]. The complete SVA genome and a 539 nt region of the VP1 gene were used to 
construct phylogenetic trees. Phylogenetic analysis was performed using the neighbor-
joining method in MEGA 6 (MEGA, version 6) [44]. The codon positions included in the 
analysis were the 1st, 2nd, 3rd, and non-coding.   
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Nucleotide sequence accession numbers. The complete genome sequences of SVA 
isolates MN15-84-4 (swab from mortality tractor bucket), MN15-84-8 (mouse fecal 
sample), MN15-84-M3 (mouse small intestine), MN15-84-21 (swab from internal 
hallway) and MN15-84-22 (lesion swab from sow) are available on GenBank under 
accession numbers KU359210, KU359211, KU359212, KU359213, KU359214. 
Results 
Clinical history and SVA diagnosis (Case herd A). On September 26, 2015 an outbreak 
of acute watery diarrhea followed by profound lethargy was observed in 3-7-day old piglets 
in two farrowing rooms of herd A. Morbidity of approximately 75% and mortality rates of 
50% were observed in piglets housed in the affected farrowing rooms. Clinical signs 
including lethargy and diarrhea were subsequently observed in piglets from two other 
farrowing rooms of this farm (over 5-7 days), with morbidity and mortality rates of 25% 
and 15%, respectively. On September 29, 2015, an acute outbreak of vesicular disease was 
observed in approximately 75% of the sows in the gestation barns of herd A. Vesicles 
ranging from 1-3 cm in diameter were observed on the snout and coronary bands of affected 
sows and after 5-10 days these vesicles ruptured leaving a dry scab in the affected skin. 
Affected sows also presented vesicles in the dewclaws and demonstrated lameness.    
The diagnostic investigation conducted at the UMN VDL revealed the presence of 
SVA nucleic acid in oral swabs collected from affected sows (seven out of seven tested 
[7/7]) and in intestinal homogenates from affected piglets (3/3). A summary of the 
diagnostic results is presented in Table 1. All tests performed for other vesicular diseases 
(FMDV, VSV, VES, and SED) resulted negative.    
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Clinical history and SVA diagnosis (Case herds C and D). Clinical signs were first 
observed in sows in the gestation barn of herd C on October 30, 2015. Initially, five animals 
presented vesicular lesions, including one sow with vesicles on the snout and coronary 
band of the hoof (Fig. 1) and four sows with ruptured vesicles on the snout. A total of 28 
sows (25 in the gestation barn and three in the maternity barn) and two boars were affected 
(morbidity of 15%). Piglets were not affected in this herd. Six sows presented lameness 
and three days later ulcerative lesions were observed on the wall of the hoofs.  
On November 3, clinical signs were observed in two sows in the maternity room of 
herd D (located at 0.2 kilometers from herd C). One sow presented an intact vesicle on the 
snout and another sow had a ruptured vesicle on the snout (morbidity of 1.5%). 
Interestingly, a sudden increase in neonatal mortality was observed in 3-5 day-old piglets. 
Mortality rates in piglets reached up to 34% one week after the first vesicular lesions were 
observed in the sows. In addition, the suckling piglets presented lethargy and watery 
diarrhea, over a period of approximately 5-7 days.  
Diagnostic investigation conducted at Embrapa revealed the presence of SVA 
nucleic acid, in various clinical samples including vesicular fluid collected from the 
lesions, skin of ruptured vesicles, and in the small intestine, tonsil and coronary band of 
affected piglets. No SVA was detected in nasal swabs (Table 1). At necropsy, the piglets 
presented enlargement and edema of inguinal lymph nodes, empty stomach, ascites, severe 
edema of the mesocolon, and severe necrosis of the coronary bands (data not shown). 
Detection of Senecavirus A in environmental samples. Environmental samples collected 
from case herd A and from unaffected herd B were screened by rRT-PCR. All samples 
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were collected following standard sampling protocols (17–19), processed for viral RNA 
isolation and screened by SVA rRT- PCR at the SD ADRDL. A summary of the rRT-PCR 
screening results is presented in Table 2. Senecavirus A was detected in clinical samples 
(lesion swabs) and multiple environmental samples collected in the interior and exterior 
areas of the affected farm. Notably, the virus was detected in mouse fecal samples collected 
in bait boxes in the interior and exterior areas of case herd A. Additionally, the small 
intestine collected from a mouse on farm A was positive for SVA (Table 2; Fig. 2). All 
other tissues collected from this mouse, including heart, brain and lungs, were negative for 
SVA (Table 2). Fly samples collected in the affected farm (herd A) and in the unaffected 
farm (herd B) were also positive for SVA nucleic acid. In addition, a pool of flies collected 
in herd C (Brazilian farm) tested positive for SVA (Table 2).  
Isolation of Senecavirus A from environmental samples. Virus isolation (VI) was 
performed in select SVA PCR positive samples to assess the presence of viable virus. All 
VIs were performed in a highly permissive human non-small lung carcinoma cell line 
(H1299) (20). SVA isolation, as evidenced by development of CPE in inoculated cell 
cultures (Fig. 2A), was confirmed by rRT-PCR (Table 2) and by immunofluorescence 
assays (Fig. 2B). A summary of the VI results is presented in Table 2. Senecavirus A was 
isolated from multiple environmental samples. Most interestingly, SVA was consistently 
isolated from mouse fecal samples, and from a mouse small intestine collected in case herd 
A. No virus was isolated from PCR positive fly samples.  
Genetic comparisons and phylogenetic analysis.  Complete genome sequences of five 
SVA isolates (SVA-MN15-84-4, -MN15-84-8, -MN15-84-21, -MN15-84-22, and -MN15-
308-M3) obtained from case herd A were compared to other SVA sequences available on 
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GenBank. Complete genome sequence comparisons revealed that the isolates characterized 
here share 93-94% nucleotide identity with the prototype US SVA strain SVV001, 96% nt 
identity with an isolate obtained in Canada in 2011 (SVA-11-55910-3), 98-99% nt identity 
with other contemporary isolates recently obtained in the US (IA40380/2015, 
IA46008/2015 and SD41901/2015, 97% nt identity with Brazilian isolates (BRA-
MG1/2015, BRA-MG2/2015 and BRA-GO3/2015) and 96% nt id with a recent Chinese 
isolate (CH-1-2015) (Table 3). Comparison of the amino acid sequences of SVA 
polyprotein (2181 aa) revealed that the MN isolates here share 97-99% aa identity with 
other SVA strains (Table 3). Comparisons based on a 541 nt region of the VP1 gene, 
revealed a similar genetic heterogeneity between these isolates (Table 4). A greater genetic 
divergence (86-88% nt id), however, was observed when the MN isolates were compared 
to historical isolates obtained prior to 2002 (Table 4).  
Phylogenetic reconstructions based on complete genome sequences or the VP1 
gene show a clear phylogenetic separation between historical- (1988-2002) and 
contemporary- (2007-2015) SVA strains (Fig. 3; Fig. 4). Phylogenetic analysis based on 
the VP1 gene revealed that all the isolates obtained here cluster with other SVA strains 
currently circulating in swine in the US (Fig. 3).  Similarly, contemporary SVA isolates 
from distinct geographic locations (i.e US, Brazil and China) form separate phylogenetic 
clusters (Fig. 3; Fig. 4). The virus that appears most closely related to the isolates 
characterized here is the strain SVA-IA40380/2015, obtained from an exhibition pig in 
Iowa (8) (Fig. 3 and Fig. 4).   
Discussion 
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Senecavirus A has been associated with sporadic outbreaks of vesicular disease in 
pigs in the US since the late 1980’s [4, 5, 13, 15]. Recently, however, an increased number 
of reports have described the association of SVA with vesicular disease and neonatal 
mortality in swine [22, 38]. Notably, the number of cases of SVA has jumped from two in 
2014 to over 100 in 2015 (Swine Health Monitoring Project, December 2015 report), which 
represents a significant increase in the incidence of infection. Since November 2014, SVA 
has also been frequently reported in swine in Brazil [21, 22]. However, the factors that 
contributed for the re-emergence of SVA in the US and its emergence in Brazil remain 
unknown.  
Here, we present the findings of a diagnostic investigation conducted in two swine 
breeding farms located in high swine density areas in the US and Brazil. In September and 
October 2015, outbreaks of vesicular disease and neonatal mortality were confirmed in two 
swine breeding farms located in Minnesota and in the Brazilian state of Santa Catarina. 
Senecavirus A nucleic acid was detected in vesicular fluid, oral and lesion swabs (coronary 
bands) from affected sows and in intestinal homogenates, tonsil and coronary swabs from 
affected piglets (Table 1). These findings corroborate the results of recent reports that 
describe the association of SVA with vesicular disease and neonatal mortality in swine [21, 
22, 39]. Additionally, results here are consistent with studies that demonstrated the 
detection of SVA in vesicular fluid, lesion swabs, lesion scrapings, and oral swabs, 
indicating that these specimens are appropriate for SVA diagnosis [21, 45]. SVA nucleic 
acid has also been detected in serum and various tissues from affected animals (lymph 
nodes, tonsil, spleen and lung) [22, 45]. Notably, piglets that died during SVA outbreaks 
presented high viral load in multiple tissues including brain, liver, lung, heart, kidney, small 
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intestine and colon [39]. Interestingly, SVA nucleic acid was not detected in nasal swabs 
collected from affected sows from herd C here (Table 1), whereas the possibility that they 
contained low amounts of viral nucleic acid bellow the detection limit of the RT-PCR assay 
used for testing cannot be formally excluded.    
Clinically, the outbreaks investigated here were characterized by lethargy, watery 
diarrhea and increased neonatal mortality (15-50% in piglets less than seven days of age), 
which occurred concomitantly with vesicular lesions (snout and coronary bands) and 
lameness in sows (morbidity ranging from 1.5% to 75%). Clinical signs and neonatal 
mortality lasted for approximately five to ten days, when lesions started to subside and 
neonatal mortality decreased to pre-outbreak rates (5-8%). The morbidity and mortality 
rates observed here are similar to those described in recent reports of SVA outbreaks in 
Brazil and the US [21, 22, 38, 39]. Historically, SVA has been associated with vesicular 
lesions in adult animals [4, 13, 15, 21], whereas common findings in recent outbreaks 
include diarrhea and sudden death in suckling piglets [22]. Similarly, in the outbreaks 
investigated here, piglets presented diarrhea, lethargy and mortality, which were followed 
by the development of vesicular lesions in sows. This was observed in two of the three 
affected herds (A and D), while in the third herd (C) only sows presented clinical signs 
(vesicular lesions and lameness). Although several aspects of SVA infection biology 
remain unknown (i.e. the pathogenesis of the disease in swine), our study presents 
additional evidence demonstrating the association of SVA with vesicular disease and 
neonatal mortality in pigs. Detection and isolation of the virus from lesions and tissues 
from affected animals coupled with the absence of other pathogens known to cause 
vesicular and/or enteric disease in swine strengthen the notion that SVA could be the cause 
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of these distinct clinical presentations in swine. Indeed, vesicular disease has been recently 
reproduced in pigs inoculated with SVA (L. R. Joshi and D. G. Diel, unpublished data; K.J. 
Yoon, presented at the 2015 NA PRRSV Symposium and Conference for Research 
Workers on Animal Health Meeting, Chicago, IL, 5 to 8 December 2015), confirming the 
role of the virus as the etiologic agent of SIVD.  
After the confirmation of SVA infection in pigs (Table 1), an investigation was 
conducted to assess possible sources of SVA within affected herds. For this, multiple 
environmental samples (Table 2) were collected from affected herd A and tested for the 
presence of SVA. SVA nucleic acid was detected and viable virus recovered from various 
environmental samples from herd A, including swabs from internal and external building 
surfaces, and farm tools and equipment. Interestingly, SVA was also detected and isolated 
from mouse fecal samples and from a mouse (Mus musculus) small intestine collected from 
farm A (Table 2; Fig. 2). Additionally, SVA nucleic acid was detected in houseflies (Musca 
domestica) collected within the premises of the affected farm A. Following detection of 
SVA in mouse and houseflies in herd A, we collected these samples from an unaffected 
farm in the US (herd B) and from affected (herd D) and unaffected farms (herd E) in Brazil. 
Notably, SVA nucleic acid was detected in houseflies collected on the exterior of the 
unaffected farm in the US (herd B; located at 0.3 kilometers of affected farm A), and on a 
pool of flies collected in the affected farm in Brazil (herd D) (Table 2). Results here 
demonstrate viable SVA in various environmental samples including farm tools, building 
surfaces and equipment and in multiple mouse samples (feces and intestine) collected in 
the SVA affected farm A. Given that these samples were collected after the SVA outbreak 
in swine, it is not possible to draw definitive conclusions about the source of the virus 
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responsible for the outbreak. However, these results suggest that farm tools and equipment 
can potentially function as fomites and transfer SVA to susceptible animals within affected 
herds. Most interestingly, our data demonstrating that mice can carry and, perhaps, shed 
SVA in feces (Table 2), suggest that these pests may contribute to the spread of SVA within 
affected herds. Additional sampling and testing are needed, however, to determine the 
actual role of this species on the ecology of SVA. It would be interesting, for example, to 
collect mouse samples in areas where SVA has not been detected in swine to assess whether 
this species functions as a natural reservoir for SVA. Although no viable SVA was 
recovered from rRT-PCR positive housefly samples tested here, detection of the virus on 
this pest deserves consideration.  
Mice and houseflies are among the most common and widely distributed pests, and 
have been frequently associated with infectious disease transmission to humans and 
animals [46, 47]. They can serve as natural reservoirs or mechanical vectors for several 
bacterial and viral pathogens, including various picornaviruses such as enteroviruses and 
ECMV which are known to infect humans, pigs and other animal species [46, 47]. Results 
here showing that mice can carry viable SVA (small intestine and feces) and flies can carry 
the virus’ nucleic acid, suggest that these species may play a role in SVA ecology. 
Detection of SVA in mice, corroborate early serologic surveys that have shown the 
presence of neutralizing antibodies against SVA in this species (14% of samples tested 
were positive) [5]. Although the results presented here demonstrate the association of SVA 
with mice and houseflies, additional studies are needed to define the actual role and 
contribution of these species for SVA infection biology and epidemiology. Studies 
designed to assess the susceptibility of mice to SVA infection and to define sites of virus 
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replication and routes and duration of virus shedding, and to assess the survival of SVA in 
houseflies would shed light on the potential role of these pests on SVA ecology and the 
actual risk they may pose to swine.  
Many factors may have contributed for the recent emergence of SVA in swine [48], 
including the genetic evolution of contemporary virus strains (Fig. 3 and Fig. 4). Genetic 
comparisons between historical- (obtained between 1988 and 2002) and contemporary 
SVA isolates (obtained between 2007 and 2015) here, revealed a high genetic diversity 
between these viruses (86-88% at the VP1 gene; and 93-94% nt identity when the complete 
genome sequence was compared). All contemporary isolates sequenced to date (including 
those obtained in the US, Brazil and most recently in China), however, share 96-99% nt 
identity. Additionally, phylogenetic analysis and inference of the evolutionary distances 
(data not shown) between SVA isolates, revealed a marked evolution of contemporary 
SVA isolates, when compared to historical viral strains (Fig. 3, and Fig.4). These 
evolutionary changes may have resulted in: 1. an increased adaptation of SVA to pigs; or 
yet, 2. an improved ability of the virus to spread between hosts and/or natural reservoirs. 
These possibilities, however, await experimental confirmation.  
 In summary, here we describe the detection of Senecavirus A in swine presenting 
vesicular disease and neonatal mortality and in two common and widely distributed pests, 
mice and houseflies. These results provide the first evidence of live SVA in mice, 
corroborating the findings of Knowles at al. who detected neutralizing antibodies against 
SVA in this species [5]. These observations suggest that mice and houseflies may play a 
role on SVA epidemiology.   
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Table 1. Detection of SVA in clinical samples following outbreak of vesicular disease in 
sow herds in the US and in Brazil. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aHerd A located in Minnesota; bHerds C and D located in Santa Catarina, Brazil. Samples 
from herd A were tested by rRT-PCR while samples from herd C and D were tested by 
conventional RT-PCR. cPooled small and large intestine homogenate. ND: not detected. 
*These animals presented vesicular lesions. Vesicular fluids tested positive for SVA while 
nasal swabs were negative. 
 
Herd Sample 
ID 
Sample Description PCR Result 
Aa Sow 1 Oral swab Positive 
 Sow 2 Oral swab Positive 
 Sow 3 Oral swab Positive 
 Sow 4 Oral swab Positive 
 Sow 5 Oral swab Positive 
 Sow 6 Oral swab Positive 
 Sow 7 Oral swab Positive 
 Piglet 1 Intestinec Positive 
 Piglet 2 Intestine Positive 
 Piglet 3 Intestine Positive 
Cb Sow 150 Nasal swab ND 
 Sow 154* Vesicular fluid Positive 
  Nasal swab ND 
 Sow 190  Nasal swab ND 
 Sow 271*  Vesicular fluid Positive 
  Nasal Swab ND 
  Coronary band of the hoof Positive 
 Sow 278 Nasal swab ND 
 Sow 346 Nasal swab ND 
 Sow 798 Vesicular fluid Positive 
 Sow 767 Vesicular fluid Positive 
 Sow 820 Nasal swab ND 
 Sow 966 Nasal swab ND 
 Sow 975 Nasal swab ND 
 Sow 988* Vesicular fluid Positive 
  Nasal swab ND 
 Sow 1170  Nasal swab ND 
 Sow 1551 Nasal swab ND 
 Piglet 262 Intestine ND 
 Piglet Intestine Positive 
Db Piglet 1 Tonsil Positive 
 Piglet 2 Tonsil Positive 
 Piglet 2 Coronary band of the hoof  Positive 
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Table 2. Detection and isolation of SVA from environmental samples collected in swine 
herds in the US and in Brazil. 
Herd Sample ID Sample Description Real-time 
PCR (Ct) 
Virus 
Isolation 
(VI) 
VI 
Confirmation 
Real-time 
PCR (Ct) 
A 1 Feed residue inside of bins  ND   
 2 Dust from exhaust fans 28.34 Positive 9.20 
 3 Ground outside farm 29.62 Positive 8.48 
 4¥ Mortality tractor bucket 31.6 Positive 10.37 
 5 Vet vehicle cab ND   
 6 Mouse feces in bait boxes (Gestation) 30.59 Positive 9.57 
 7 Mouse feces in bait boxes (Gestation) 28.61 Positive 8.88 
 8¥ Mouse feces in bait boxes (Gestation) 28.84 Positive 11.60 
 9 Mouse feces in bait boxes (Farrowing) 35.74 NT  
 10 Mouse feces in bait boxes (Farrowing) 35.72 NT  
 11 Mouse feces in bait boxes (Farrowing) 36.8 NT  
 12 Antibiotic A injectable ND   
 13 Oxytocin injectable ND   
 14 Antibiotic B injectable 34.89 NT  
 15 Gentamycin injectable ND   
 16 Mycoplasma hyopneumoniae vaccine ND   
 17 Acepromazine injectable ND   
 18 PCV2 vaccine ND   
 19 Vitamin K injectable ND   
 20 Prostaglandin injectable ND   
 21¥ Internal hallway swab  22.92 Positive 11.42 
 22¥ Snout lesion swab from affected sow 18.95 Positive 11.83 
 23 Semen used prior to outbreak ND   
 24 Semen used prior to outbreak ND   
 25 Office mouse bait box 34.95 NT  
 26 Office floor ND   
 27 Concrete pad entrance door 36.75 NT  
 28 Personnel hands & footwear swabs ND   
 29 Personnel hands & footwear swabs ND   
 30 Personnel hands & footwear swabs ND   
 31 Personnel hands & footwear swabs ND   
 32 External mouse feces  32.16 Positive 9.78 
 33 External mouse feces  35.81 Positive 9.07 
 34 External mouse feces  35.74 Negative  
 35 External mouse feces  ND   
 36 External mouse feces  ND   
 37 External bait box swab  33.85 Positive 9.31 
 38 External bait box swab  35.02 Positive 7.62 
 39 External bait box swab  ND   
 40 External bait box swab  ND   
 41 Feces collected on mice nest outside the farm  ND   
 42  Small intestine - Mouse collected outside (M1) ND   
  Spleen-M1 ND   
  Liver-M1 ND   
  Heart-M1 ND   
  Lung-M1 ND   
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  Kidney-M1 ND   
  Brain-M1 ND   
 43 Small Intestine - Mouse outside (M2) ND   
 44¥ Small Intestine - Mouse collected inside (M3)¥ 30.93 Positive 13.06 
  Heart-M3 ND   
  Lung-M3 ND   
  Brain-M3 ND   
 45 Small Intestine - Mouse collected inside (M4) ND   
 46 Flies collected inside affected farm 27.27 Negative  
 47 Flies collected outside affected farm 26.39 Negative  
 48 Small Intestine - Bird collected outside ND   
      
B 1 Internal bait box swab (Gestation) ND   
 2 Internal bait box swab (Gestation) ND   
 3 Internal bait box swab (Farrowing)    
 4 Internal bait box swab (Farrowing) ND   
 5 Mouse feces exterior to farm ND   
 6 Mouse feces in bait boxes (Gestation) ND   
 7 Mouse feces in bait boxes (Gestation) ND   
 8 Mouse feces in bait boxes (Gestation) ND   
 9 Mouse feces in bait boxes (Gestation) ND   
 10 Mouse feces in bait boxes (Gestation) ND   
 11 Mouse feces in bait boxes (Gestation) ND   
 12 Mouse feces in bait boxes (Farrowing) ND   
 13 Mouse feces in bait boxes (Farrowing) ND   
 14 Mouse feces in bait boxes (Farrowing) ND   
 15 Mouse feces in bait boxes (Farrowing) ND   
 16 Mouse feces in bait boxes (Farrowing) ND   
 17 Mouse feces in bait boxes (Farrowing) ND   
 18 Small Intestine - Mouse collected outside (M1) ND   
  Spleen - M1 ND   
  Liver - M1 ND   
  Kidney - M1 ND   
  Lung - M1 ND   
  Brain - M1 ND   
 19 Flies collected outside unaffected farm B 31.67 Negative  
 20 Flies collected inside unaffected farm B ND   
 21 Flies collected outside unaffected farm B ND   
 22 Flies collected inside unaffected farm B ND   
 23 Flies collected outside unaffected farm B ND   
 24 Flies collected inside unaffected farm B ND   
 25 Flies collected outside unaffected farm B ND   
 26 Flies collected inside unaffected farm B 35.66 Negative  
      
C 1 Flies collected inside affected farm C Positive NT  
 2 Intestine mice collected inside 1 ND   
 3 Intestine mice collected inside 2 ND   
      
E 1 Flies collected inside unaffected farm ND   
A. Affected farm (Minnesota); B. Unaffected farm (MN); C. Affected farm (Santa 
Catarina, Brazil); E: Unaffected farm (SC, Brazil). ND: Not detected; NT: Not tested. 
Samples from herds A and B were tested by rRT-PCR while samples from herd C were 
tested by conventional RT-PCR. ¥ Virus isolates for which complete genome sequences 
were obtained. 
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Table 3 Complete genome sequence comparisons between the SVA isolates MN15-84-4, 
MN15-84-8, MN15-84-21, MN15-84-22 and MN15-308-M3 and other historical and 
contemporary SVA strains. 
 % identity for SVA isolatea: 
 MN15-84-4 MN15-84-8 MN15-84-21 MN15-84-22 MN15-308-M3 
SVA isolateb nt aa nt aa nt aa nt aa nt aa 
SV001 93 97 94 97 93 97 93 97 94 97 
11-55910-3 96 98 96 98 96 98 96 98 96 98 
IA40380/15 99 99 99 99 99 99 99 99 99 99 
IA46008/15 98 99 98 99 98 99 98 99 98 99 
SD41901/15 98 99 98 99 98 99 98 99 98 99 
BRAMG1/15 97 99 97 99 97 99 97 99 97 99 
BRAMG2/15 97 99 97 99 97 99 97 99 97 99 
BRAGO1/15 97 99 97 99 97 99 97 99 97 99 
CH-1-15 96 98 96 98 96 98 96 98 96 98 
MN15-84-4 - - 99 99 99 100 99 99 99 99 
MN15-84-8 99 99 - - 99 100 99 100 99 100 
MN15-84-21 99 99 99 100 - - 99 100 99 100 
MN15-84-22 99 99 99 100 99 100 - - 99 100 
MN15-308-M3 99 99 99 100 99 100 99 100 - - 
aSequence alignment performed by using CLUSTAL W (15). 
bGenBank accession numbers are DQ641257, KC667560, KT757280, KT757282, KT757281, KR063107,  
KR063108, KR063109, KT321458, KU359210, KU359211, KU359212, KU359213, KU359214, 
respectively. 
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Table 4. Comparison of nucleotide sequences of VP1 gene between historical and 
contemporary SVA isolates  
 % identity for SVA isolatea 
SVA isolate MN15-84-4 MN15-84-8 MN15-84-21 MN15-84-22 MN15-308-M3 
SV001 91 91 91 91 91 
11-55910-3 94 94 94 94 94 
131395 92 93 93 93 93 
1278 90 90 90 90 90 
89-47752 88 88 88 88 88 
92-48963 87 88 88 88 88 
90-10324 87 88 88 88 88 
88-36695 86 86 86 86 86 
88-23626 86 86 86 86 86 
IA40380/15 97 100 100 100 100 
IA46008/15 99 99 99 99 99 
SD41901/15 99 99 99 99 99 
BRAMG1/15 97 97 97 97 97 
BRAMG2/15 97 97 97 97 97 
BRAGO1/15 97 97 97 97 97 
BRA/UEL-B2 97 97 97 97 97 
BRA-UEL-A1 96 97 97 97 97 
CH-1-15 96 96 96 96 96 
MN15-84-4 - 99 99 99 99 
MN15-84-4 99 - 100 100 100 
MN15-84-21 99 100 - 100 100 
MN15-84-22 99 100 100 - 100 
MN15-308-M3 99 100 100 100 - 
aA 541 nt region of the VP1 gene (nucleotide positions 2680-3220 of the genome of SVA prototype strain 
SVV001) were aligned by using CLUSTAL W (15).  
bGenBank accession numbers are DQ641257, KC667560, EU271763, EU271757, EU271762, EU271761, 
EU271760, EU271759, KT757280, KT757282, KT757281, KR063107,  KR063108, KR063109, KR075678, 
KR0756787, KT321458, KU359210, KU359211, KU359212, KU359213, KU35921,4 respectively. 
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Fig 1. Clinical presentation of Senecavirus A in sows. Vesicular lesions on the snout (A) 
and coronary bands (B) a sow from herd C. (A) Large vesicles (1-3 cm in diameter, orange 
arrow) were filled with fluid, ruptured and dried out after 5-10 days leaving a dry scab 
covering the affected skin. (B) Dried scab (yellow arrow) on the wall of the hoof and 
ruptured vesicle on the coronary band (orange arrow).  
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Fig 2. Isolation of Senecavirus A in cell culture. (A) Cytopathic effect (rounded cells) 
observed in H1299 non-small lung cell carcinoma cells following inoculation of mouse 
fecal sample into semi-confluent monolayers (48 hours post inoculation; right panel). 
Mock-infected control cells (left panel). (B)  Immunofluorescence assay confirming 
isolation of SVA from environmental samples. SVA specific monoclonal antibody (F61 
SVV-9-2-1 (13), left panels) or convalescent serum (right panels) were used. SVA isolates 
shown were obtained from a swab from the snout of a sow (SVA-MN15-84-22), mouse 
small intestine (SVA-MN15-308-M3), mouse fecal sample (SVA-MN15-84-8), and from 
an environmental swab (SVA-MN15-84-21). Magnification 200X, scale bar 50 µm. 
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Fig 3. Evolutionary relationships of Senecavirus A based on complete genome sequences. 
The evolutionary history was inferred using the Neighbor-Joining method [49]. The 
optimal tree with the sum of branch length = 0.11793138 is shown. The percentage of 
replicate trees in which the associated taxa clustered together in the bootstrap test (1000 
replicates) are shown next to the branches [43]. The tree is drawn to scale, with branch 
lengths in the same units as those of the evolutionary distances used to infer the 
phylogenetic tree. The evolutionary distances were computed using the Maximum 
Composite Likelihood method [50] and are in the units of the number of base substitutions 
per site. The analysis involved 14 nucleotide sequences. Codon positions included were 
1st+2nd+3rd+Noncoding. All positions containing gaps and missing data were eliminated. 
There were a total of 7098 positions in the final dataset. Evolutionary analyses were 
conducted in MEGA6 (16). 
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Fig 4. Evolutionary relationships of Senecavirus A based on the VP1 gene. The 
evolutionary history was inferred using the Neighbor-Joining method  [49]. The optimal 
tree with the sum of branch length = 0.21986844 is shown. The percentage of replicate 
trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) 
are shown next to the branches [44]. The tree is drawn to scale, with branch lengths in the 
same units as those of the evolutionary distances used to infer the phylogenetic tree. The 
evolutionary distances were computed using the Maximum Composite Likelihood method 
[50] and are in the units of the number of base substitutions per site. The analysis involved 
22 nucleotide sequences. Codon positions included were 1st+2nd+3rd+Noncoding. All 
positions containing gaps and missing data were eliminated. There were a total of 539 
positions in the final dataset. Evolutionary analyses were conducted in MEGA6 [43]. 
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ABSTRACT 
Senecavirus A (SVA) is an emerging picornavirus that has been recently associated 
with vesicular disease and neonatal mortality in swine. Many aspects of SVA infection 
biology and pathogenesis, however, remain unknown. Here the pathogenesis of SVA was 
investigated in finishing pigs. Animals were inoculated via the oronasal route with a 
contemporary SVA strain SD15-26 and monitored for clinical signs and lesions associated 
with SVA infection. Viremia was assessed in serum and virus shedding monitored in oral 
and nasal secretions and feces by real-time reverse transcriptase PCR (RT-qPCR) and/or 
virus isolation. Additionally, viral load and tissue distribution were assessed during acute 
infection and following convalescence from disease. Clinical signs characterized by 
lethargy and lameness were first observed on day 4 post-inoculation (pi) and persisted for 
~2-10 days. Vesicular lesions were observed on the snout and feet, affecting the coronary 
bands, dewclaws, interdigital space and heel/sole of SVA-infected animals. A short-term 
viremia was detected between days 3-10 pi, whereas virus shedding was detected between 
days 1-28 pi in oral and nasal secretions and feces. Notably, RT-qPCR and in situ 
hybridization (ISH) performed on tissues collected on day 38 pi revealed the presence of 
SVA RNA in the tonsil of all SVA infected animals. Serological responses to SVA were 
characterized by early neutralizing antibody responses (5 days pi), which coincided with a 
progressive decrease in the levels of viremia, virus shedding and viral load in tissues. This 
study provides significant insights on the pathogenesis and infectious dynamics of SVA in 
swine.  
Key words: Senecavirus A, SVA, Seneca Valley virus, SVV, vesicular disease, swine. 
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Introduction 
Senecavirus A (SVA), previously known as Seneca Valley virus, is a non-
enveloped single-stranded positive sense RNA virus of the genus Senecavirus, family 
Picornaviridae [1, 7]. The Picornaviridae comprises over 50 viruses that cause disease in 
humans and several animal species [51]. Some of the most important picornaviruses 
include enterovirus A through J, rhinovirus-A, -B and -C, and foot-and-mouth disease virus 
(FMDV) [6, 51].  SVA is closely related to members of the genus Cardiovirus, including 
cardiovirus A (encephalomyocarditis virus, EMCV) and -B (Theiler’s murine 
encephalomyelitis virus, TMEV) (ICTV, 2015), which infect a wide range of vertebrate 
species, including humans, pigs, and mice [1, 37]. 
The SVA genome is approximately 7.2 kb in length and contains a unique open 
reading frame (ORF) that is flanked by 5’ and 3’ untranslated regions (UTRs), with the 3’-
UTR being followed by a poly(A) tail [1]. The single ORF present in the SVA genome, 
encodes a large polyprotein that is cleaved by viral encoded proteases into twelve mature 
viral proteins (5’-L-VP4-VP2-VP3-VP1-2A-2B-2C-3A-3B-3C-3D-3’) [1]. Notably, 
amino acid sequence comparisons between SVA and other picornaviruses revealed a higher 
degree of similarity between SVA and cardioviruses within the VP4-VP1 region and in the 
2C, 3C and 3D proteins; whereas the remaining proteins of SVA are considerably different 
from their homologues in other known picornaviruses [1]. 
SVA was originally identified as a cell culture contaminant in the United States 
(US) in 2002 [5]. Sequencing of picorna-like viruses isolated from pigs with various 
clinical presentations, however, revealed the presence of SVA in the US swine population 
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since late 1980’s [5]. Since its identification in 2002, SVA has been associated with 
sporadic cases of vesicular disease in pigs in the US [15, 35] and Canada [13]. Interestingly, 
since November 2014 several outbreaks of vesicular disease associated with SVA have 
been reported in Brazil [21, 22, 25]. Additionally, in March 2015 SVA was detected during 
an outbreak of vesicular disease in China [52], and since July 2015 an increasing number 
of cases have been reported in the US [23, 25, 35]. The factors that led to the surge on SVA 
outbreaks remain unknown. Interestingly, sequence analysis of current SVA isolates 
circulating in the US, Brazil and China and comparison of these isolates with historical 
SVA strains, revealed a marked genetic diversity (91-93%) between contemporary and 
historical SVA strains [25]. Whether these genetic changes have contributed to the 
emergence of SVA remains to be determined.  
Characteristic lesions observed in the recent SVA outbreaks include vesicles on the 
snout, oral mucosa, and coronary bands, while common clinical signs include lameness 
and lethargy. Additionally, diarrhea and increased neonatal mortality in piglets less than 
seven days of age have also been reported [23, 25]. Multiple experimental studies 
conducted with historical SVA isolates failed to reproduce the disease in pigs [5, 19], 
recently, however, vesicular disease was reproduced in animals inoculated with a 
contemporary US SVA isolate, confirming the role of the virus in the etiology of vesicular 
disease in pigs [20]. Clinically, lesions induced by SVA are indistinguishable from those 
seen in other vesicular diseases of swine including foot-and-mouth disease, vesicular 
stomatitis, swine vesicular disease and vesicular exanthema of swine [13, 15, 53], which 
highlights the importance of rapid and accurate diagnosis and differentiation of vesicular 
disease causing agents of swine.  
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Although SVA has been recently linked to vesicular disease in pigs [20], many 
aspects of its infection biology and pathogenesis remain unknown. Here, the pathogenesis 
of a contemporary SVA strain SD15-26 was evaluated following experimental infection of 
finishing pigs. The dynamics of infection and viremia, patterns of virus shedding and viral 
load and tissue distribution were assessed by real-time reverse transcriptase PCR (RT-
qPCR) and virus isolation. Serological responses to SVA were evaluated by virus 
neutralization, and immunofluorescence assays. Results here provide important insights on 
the pathogenesis of SVA-induced vesicular disease in swine.  
Results  
Characterization of Senecavirus A isolate SD15-26. The SVA isolate SD15-26 was 
obtained from a vesicular swab collected from finishing pigs presenting vesicles on the 
snout and coronary bands. The virus was isolated in NCI-H1299 human non-small cell 
lung carcinoma cells and low passage viral stocks (passage 4) were used in all experiments 
described here. All samples subjected to virus isolation were positive for SVA by RT-
qPCR and tested negative for other vesicular disease agents of swine (FMDV, vesicular 
stomatitis virus [VSV], swine vesicular disease virus [SVDV] and vesicular exanthema of 
swine [VES]) at the Foreign Animal Disease Diagnostic Laboratory at the Plum Island 
Animal Disease Center (PIADC). The complete genome sequence of SVA SD15-26 was 
determined by next generation sequencing using the Illumina MiSeq sequencing platform 
and complete genome sequence comparisons between the SVA SD15-26 isolate and other 
SVA strains available on GenBank, revealed 98-99% nt identity with contemporary SVA 
strains and only 91% nt identity with the historical SVA prototype strain SVV-001 (Hales 
et al., 2008). The genome of SVA SD15-26 is 7,266 nt in length (G + C content of 52%) 
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and encodes a single open reading frame of 2,181 amino acids (GeneBank accession no. 
KX778101).  
The replication properties of SVA SD15-26 were assessed in H1299 cell cultures 
and compared to its replication ability in cell lines derived from swine (porcine kidney-15, 
PK-15). Single-step (multiplicity of infection [MOI] = 10) or multi-step (MOI = 0.1) 
growth curves were performed in both cell lines and viral yields determined at different 
intervals post-inoculation (pi). SVA SD15-26 replicated efficiently in both cell lines with 
peak viral titers being detected at 72 h pi. Replication kinetics of SVA in H1299 and PK-
15 cells were similar at low and high MOIs. 
Infection of pigs with SVA SD15-26 results in vesicular disease. The pathogenicity of 
SVA SD15-26 and its ability to cause vesicular disease were assessed in finishing pigs. 
Eight fifteen-week-old finishing pigs (~55 kg of weight), were inoculated via the oronasal 
route (half the inoculum was given orally and the other half intra-nasally) and monitored 
for characteristic SVA clinical signs and lesions during a 38-day experimental period. All 
SVA inoculated pigs (n = 8) presented lameness and lethargy by day 4 pi and these signs 
persisted for ~2-10 days. Vesicular lesions were first observed on the feet and/or snout of 
SVA inoculated animals on day 4 pi (6 of 8 animals). Initial observations consisted of 
erythema in the skin, which progressed and developed into vesicles ranging from 0.5 to 3 
cm in diameter. The vesicles ruptured around day 5-6 pi, leaving an erosion in the skin, 
which subsequently evolved forming a crust in the affected area (day 8-9 pi). Lesions were 
completely resolved by days 12-16 pi (Fig. 5a). Two animals presented (2/8; no. 45 and 
46) only erythematous areas on the snout which persisted for 2-4 days (Fig. 5b). It is 
important to note that animal no. 46 died of unrelated causes on day 7 pi.  
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The presence of SVA in the lesions was confirmed by RT-qPCR (data not shown) 
and/or by in situ hybridization (ISH) (Fig. 5c). Lesions that developed on the feet of SVA-
infected animals presented similar progression to those observed on the snout (Fig. 5a and 
Fig. 5b), with vesicles being observed on the heel/sole of the feet, interdigital space, 
dewclaws and/or coronary bands (Fig. 5b). Control group pigs (n = 4) did not exhibit any 
clinical signs or pathological changes. No significant differences were observed on the 
rectal temperature of control and SVA infected pigs.  
SVA infected pigs present a short-term viremia. The levels of viremia were assessed in 
serum of SVA inoculated pigs. Serum samples collected on days 1, 3, 5, 7, 10, 14, 21, 28, 
35 and 38 pi were evaluated for the presence of SVA using RT-qPCR. SVA was detected 
between days 3 and 10 pi (Table 5; Fig. 6a). Peak SVA genome copies were detected on 
day 3 pi, progressively decreasing thereafter with no viral RNA being detected after day 
10 pi (Table 5; Fig. 6a). One SVA inoculated animal did not present viremia (animal no. 
44, Table 5). Notably, virus isolation attempts in RT-qPCR positive serum samples led to 
isolation of SVA from only two samples (2/6) on day 3 pi, with no virus being isolated 
from serum after day 3 pi. These results indicate that SVA induces a short-term viremia in 
pigs, with viral RNA being detected in serum during a period of ~7 days (3-10 days pi), 
which coincided with the acute clinical phase of the disease.    
SVA inoculated pigs shed virus in oral and nasal secretions and in feces. The dynamics 
and patterns of virus shedding were evaluated in oral and nasal secretions and in feces. 
Oral, nasal and rectal swabs were collected on days 0, 1, 3, 5, 7, 10, 14, 21, 28, and 35 pi 
and screened for the presence of SVA. Virus shedding was detected up to day 28 pi by RT-
qPCR, with all infected animals shedding SVA in oral and nasal secretions and in feces 
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between days 3 and 14 pi (Table 5). After day 14 pi a transient shedding pattern was 
observed, with a few animals (4/7) shedding virus up to day 28 pi (Table 5). No virus 
shedding was detected on day 35 pi (Table 5). The amount of SVA present in oral and nasal 
secretions and in feces was quantitated and expressed as genome copy number per mL (Fig. 
6b). Peak viral shedding was observed between days 1 and 5 pi, with higher amounts of 
SVA RNA (0.5-1 log10) being detected in oral secretions until day 5 pi.  The levels and 
frequency of SVA shed by infected animals gradually decreased between days 5 and 28 pi, 
with no virus being detected on samples collected on day 35 pi (Table 5; Fig. 6b).   
Shedding of infectious SVA in oral and nasal secretions and feces was assessed by 
virus isolation [54] in RT-qPCR positive samples. SVA was isolated from oral secretions 
up to day 21 pi, while nasal secretions and fecal samples contained infectious virus up to 
day 7 and 10 pi, respectively (Table 6). The amount of infectious SVA was quantitated by 
limiting dilution and viral titers determined as per the Spearman and Karber’s method [55], 
and expressed as tissue culture infectious dose 50 (TCID50) per mL on samples collected 
on days 3, 7 and 21 pi. Higher viral titers were detected in oral secretions on day 7 pi, with 
individual titers ranging from 2-3.5 log10 TCID50/mL. Notably, 5/7 animals were still 
shedding SVA in oral secretions on day 21 pi (1.75-2.25 log10 TCID50/mL). In general, 
lower amounts of SVA were detected in nasal secretions and feces of SVA infected animals 
(Fig. 6b).  
Viral load and tissue distribution during the acute stage of SVA infection. Viral load 
and tissue distribution were investigated during the acute stage of SVA infection. For this, 
four animals used as mock infected controls during the clinical phase of the experiment 
were inoculated with SVA (experimental day 35; same dose and inoculation route) and 
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euthanized on days 3, 4, 5 and 6 pi (one animal per day). A fifth animal (no. 46) which 
died of unrelated causes on day 7 pi was included in this study. Tissues including lung, 
mediastinal lymph node, heart, liver, spleen, mesenteric lymph node, small intestine, large 
intestine, kidney and tonsil were collected and processed for RT-qPCR, virus isolation, 
histological examination and/or in situ hybridization (ISH). Two of these animals (2/4) 
developed vesicular lesions in the coronary bands and the presence of SVA on these skin 
lesions was confirmed by ISH. SVA nucleic acid was consistently detected between days 
3 and 7 pi in the lung, mediastinal and mesenteric lymph nodes, liver, spleen, small and 
large intestines and tonsil (Table 7; Fig. 7a), and viable SVA was isolated from these tissues 
between days 3 and 5 pi (Table 7). Notably, quantitation of SVA RNA in these tissues 
revealed higher levels of the virus in the tonsil of SVA infected animals (Fig. 7a) with 
infectious virus being isolated from the tonsil up to day 7 pi. Replication of SVA in the 
tonsil was confirmed by ISH and virus isolation (Fig. 7b; Table 7). These results suggest 
that the tonsil might be one of the primary sites of SVA replication during the acute stage 
of infection. 
SVA RNA is present in tissues from convalescent pigs. The presence of SVA in tissues 
was assessed following convalescence from disease. Tissues including lung, mediastinal 
lymph node, heart, liver, spleen, mesenteric lymph node, small intestine, large intestine, 
kidney and tonsil were collected on day 38 pi (~ 3.5 weeks after complete resolution of 
vesicular lesions) and processed for RT-qPCR and virus isolation. SVA RNA was detected 
in the mediastinal lymph node (6/7 animals), spleen (4/7) mesenteric lymph node (2/7), 
small intestine (2/7), large intestine (1/7), kidney (1/7) and tonsil (7/7) of SVA-infected 
animals. Notably, quantitation of viral nuclei acid by RT-qPCR demonstrated high viral 
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load in the tonsil of all SVA inoculated animals (average of ~105 genome copies) (Fig. 7c). 
The presence of SVA RNA in the tonsil was confirmed by ISH, with most viral RNA being 
detected in the subepithelial area and occasionally in lymphoid follicles (Fig. 7d). No viral 
RNA was detected in the lung, heart and liver of SVA inoculated animals. No infectious 
SVA was isolated from any of the RT-qPCR positive tissues on day 38 pi. These results 
demonstrate the presence of SVA RNA in lymphoid (lymph nodes and tonsil) and non-
lymphoid tissues (small and large intestine and kidney) following convalescence from 
vesicular disease in pigs.  
 Histopathological changes induced by SVA infection. A complete histological 
examination was performed in tissues collected during the acute (3-7 dpi) and convalescent 
stage of SVA infection (38 dpi). Histological changes observed in the skin of animals 
presenting vesicular lesions in the coronary bands (days 4-6 pi) consisted of coronary band 
dermatitis, which was characterized by multifocal separation of the dermis from the 
epidermis with cleft formation and exocytosis of inflammatory cells (Fig. 8a). Clefts 
contained large numbers of necrotic keratinocytes admixed with edema, mild hemorrhage, 
fibrin and inflammatory infiltrates consisting of macrophages, lymphocytes, plasma cells, 
and neutrophils (Fig. 8a). Additionally, the epidermis adjacent to the vesicular lesions 
presented hyperplasia with rete peg formation and anastomoses, multifocal intracellular 
edema, and mild spongiosis (Fig. 8a). 
 All other tissues including lung, mediastinal lymph node, heart, liver, spleen, 
mesenteric lymph node, small intestine, large intestine, kidney and tonsil collected during 
the acute stage of SVA infection (days 3-7 pi) or after convalescence (day 38 pi) were also 
subjected to histological examinations. Notably, during the first 3-7 days pi, histological 
49 
 
 
 
changes were restricted to lymphoid tissues (tonsil, spleen and lymph nodes) and lung. 
Typical histological changes observed in the tonsil, spleen and lymph nodes consisted of 
mild to moderate lymphoid hyperplasia (Fig. 8b). The lungs presented multifocal mild 
atelectasis and occasionally diffuse congestion with multifocal mild perivascular 
accumulation of lymphocytes, plasma cells and macrophages (data not shown). No 
histological changes were observed in the other tissues collected during acute infection 
(days 3 and 7 pi). The only histological change observed in tissues collected on day 38 pi 
was moderate lymphoid hyperplasia, which was restricted to the tonsil.   
SVA infection induced early neutralizing antibody (NA) response in pigs. The 
serological response to SVA was evaluated by indirect immunofluorescence (IFA) and 
virus neutralization assay (VN). All SVA infected animals seroconverted to SVA and 
developed an early antibody response against the virus (5-10 days; Fig. 9a and Fig. 9b). 
SVA specific IgG antibodies were first detected by IFA on day 10 pi, with most animals 
presenting high levels of SVA-specific IgG antibodies until the end of the experiment on 
day 38 pi. Additionally, all SVA-infected animals developed high levels of neutralizing 
antibodies (NA) against the virus. Notably, NA were first detected on day 5 pi, with peak 
NA titers observed on day 10 pi. High levels of NA were still detected at the end of the 
experiment on day 38 pi. Pigs in the control groups did not present antibodies against SVA 
throughout the experiment. These results demonstrate an early and robust NA response 
following SVA infection in pigs. 
Discussion 
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The goal of this study was to assess the pathogenesis and infection dynamics of 
SVA-induced vesicular disease in swine. Despite being detected in pigs presenting 
vesicular disease [13, 15]; early studies conducted with historical SVA strains failed to 
reproduce disease in pigs [5, 19]. Recently, however, experimental infection of pigs with 
contemporary SVA isolates demonstrated the ability of SVA to cause vesicular disease in 
swine [20, 34]. Results here corroborate findings from the latter studies, confirming the 
role of SVA as the etiologic agent of vesicular disease in swine. Animals inoculated with 
SVA strain SD15-26 presented characteristic clinical signs and vesicular lesions that have 
been reported in several cases of natural infection with the virus [21, 23, 25, 56]. Clinical 
disease was observed around days 4-5 pi and lasted for approximately 10-12 days. These 
observations are consistent with the findings of Chen and Montiel and collaborators [20, 
34], indicating that SVA has a short incubation period and induces an acute self-limiting 
vesicular disease in pigs. Although all SVA-inoculated pigs have seroconverted, only 8 out 
of 12 animals (~66%) developed vesicular disease. This seems to be a common feature of 
SVA, with similar morbidity rates being observed in natural cases [21-23, 25, 56] and in 
experimental infections in swine [20]. 
 Other aspects of SVA pathogenesis that were assessed in our study, included 
viremia, virus shedding and viral load and tissue distribution. Viremia coincided with the 
clinical phase of the disease (3-10 days pi), with peak viral RNA (~1 x 106.5 SVA genome 
copy number/mL) being detected in serum on day 3 pi, just prior to the appearance of 
vesicular lesions on day 4 pi. Despite the high amounts of viral RNA detected in serum 
during seven days, SVA was isolated only on day 3 pi, with no infectious virus being 
recovered from serum thereafter. Notably, levels of viremia decreased after the appearance 
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of circulating neutralizing antibodies (Fig. 6a and Fig. 6b), with the detection of NAs on 
day 5 pi correlating with the lack of virus isolation from serum. Similar patterns of viremia 
were observed in nursing pigs inoculated with another contemporary SVA strain, with the 
virus RNA being detected in serum on days 3 and 7 pi [34]. These observations indicate 
that SVA induces a short-term viremia in infected animals, and further suggest that like 
with other picornaviruses [57], neutralizing antibodies may play a role on SVA clearance 
from the blood.    
 The dynamics of virus shedding following oronasal infection with SVA was 
monitored in oral and nasal secretions and feces. Viral nucleic acid was consistently 
detected in all SVA-infected animals with at least one specimen of each animal testing 
positive for SVA for approximately three weeks pi (Table 5). Notably, oral secretions 
contained higher amounts of SVA and, most importantly, infectious SVA was recovered 
from oral secretions for two additional weeks when compared to nasal secretions and feces 
(Table 7). These findings are consistent with a previous study which detected higher 
amounts of SVA in oral fluid from SVA-infected animals [34]. The SVA shedding pattern 
in oral secretions (Table 6; Fig. 8b), suggest that the virus may replicate locally in the oral 
mucosa or, perhaps, in another associated tissue. Infectious SVA was, indeed, detected in 
the tonsil between days 3 and 7 pi, indicating that this tissue supports active replication of 
the virus and may serve as a source of virus that is shed in oral secretions. Collectively, 
these data suggest that oral-, nasal secretions and feces may serve as a source of SVA 
infection, and in addition to vesicular fluid, which contains high amounts of SVA [21-23, 
25], they could play a role on SVA transmission. Additional experiments are required, 
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however, to define the actual contribution of these secretions/excretions to SVA 
transmission in the field. 
  Tissue distribution and viral load were investigated during the acute phase of SVA 
infection.  SVA was consistently detected in the lung, lymph nodes (mediastinal and 
mesenteric), liver, spleen, small and large intestines and tonsil of SVA-infected animals 
between days 3 and 7 pi, with infectious virus being recovered from most of these tissues 
between days 3-5 pi (Table 7). Consistent with the virological findings, histological 
examination of the tonsil, spleen and lymph nodes revealed mild to moderate lymphoid 
hyperplasia, suggesting that these tissues may represent potential sites of SVA replication. 
However, given that the virus was still viremic, the possibility that detection of SVA in 
some of these tissues was due to the virus circulating in the blood cannot be formally 
excluded. Notably, levels of SVA nucleic acid detected in the tonsil were markedly higher 
than in other tissues, with infectious virus being detected in this tissue for at least seven 
days pi (Fig. 7a; Table 7). Several studies have shown that the tonsil is one of the primary 
sites of replication for multiple picornaviruses [58-61]. Results here demonstrating 
infectious virus and SVA-specific ISH staining in crypt epithelium and sub-epithelial 
mononuclear cells in the tonsil, indicate that this tissue is one of the sites of SVA replication 
during the acute phase of infection. 
 One of the most intriguing findings of our study was the detection of SVA RNA in 
tissues from convalescent animals. While the virus RNA was detected in lymph nodes, 
spleen, intestine and kidney of a few animals, all animals (7/7) presented high levels of 
SVA nucleic acid in the tonsil (1-3 logs higher than in other tissues; Fig. 3c). ISH 
performed on sections from the tonsil demonstrated a similar staining pattern to that 
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observed during the acute phase of infection, with SVA nucleic acid being detected mainly 
in epithelial cells in the crypt and in sub-epithelial mononuclear cells. Despite the detection 
of high levels of SVA RNA on these tissues, no infectious virus was recovered after three 
passages in the highly susceptible H1299 cells (data not shown) [25, 62]. The fact that SVA 
RNA was not cleared from tissues ~3.5 weeks after resolution of the clinical disease raise 
important questions about the strategies that the virus may have evolved for its maintenance 
in swine. Several picornaviruses including EMCV and FMDV are known to establish 
persistent infections in natural hosts, with carrier animals playing an important role on the 
epidemiology of these viruses [53, 63, 64]. Thus, it would be interesting to assess whether 
SVA is capable of establishing chronic/subclinical and/or persistent infection in pigs. Most 
importantly would be to assess whether infectious virus can be recovered from tissues 
and/or body secretions/excretions of convalescent animals under normal physiological 
conditions or, perhaps, after stressful stimuli. 
SVA-specific antibodies were detected at early stages of SVA infection, with 
neutralizing antibodies being first detected around day 5 pi. Early antibody responses are 
a hallmark of several picornaviruses, with first detection of antibodies usually coinciding 
with progressive clearance of the viruses from the circulation and most organs, excretions 
and secretions [57]. Similarly, here, rising levels of SVA-specific NA in serum paralleled 
with decreased disease severity (Fig. 5 and Fig. 9), lowering levels of viremia (Fig. 6a), 
and virus shedding (Fig. 6b), and decreased viral load in tissues (Table 7, Fig. 7a).  
 In summary, this study provides important insights on the infection dynamics and 
pathogenesis of SVA in swine. Results here demonstrate the acute nature of the vesicular 
disease caused by SVA in swine and shed light on the patterns of viremia and virus 
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shedding by infected animals. Virus isolation and RT-qPCR performed in tissues suggest 
that SVA has a tropism for lymphoid tissues, with higher viral loads being detected in the 
tonsil of infected animals. Results demonstrating the presence of SVA nucleic acid in 
tissues from convalescent animals recommend further investigations to assess the 
importance of these findings for the infection biology and maintenance of SVA in swine 
populations.  
Materials and Methods  
Cells and viruses. NCI-H1299 were obtained from the American Type Culture Collection 
(ATCC-CRL 5803) and cultured at 37°C with 5% CO2 in RPMI 1640 medium 
supplemented with 10% fetal bovine serum and 2 mM L-glutamine and containing 
penicillin (100 U/mL), streptomycin (100 µg/mL) and gentamycin (50 µg/mL). PK-15 
were cultured at 37°C with 5% CO2
 in the same culture medium described above. 
Senecavirus A isolate SD15-26 was obtained from a lesion swab collected from a 
finishing pig presenting vesicular disease in the state of South Dakota in 2015. Swab and 
serum samples were submitted to the SD Animal Disease Research and Diagnostic 
Laboratory and referred to the Foreign Animal Disease Diagnostic Laboratory at the 
PIADC for foreign animal disease (FAD) investigation. SVA positive swab samples were 
processed for virus isolation as previously described (Joshi et al., 2016) and inoculated in 
semi-confluent (60-70%) monolayers of H1299 cells. Cells were monitored daily for five 
days for the development of cytopathic effect (CPE) and SVA isolation was confirmed by 
RT-qPCR and immunofluorescence assays. Low passage (p.4) SVA stocks were prepared 
and titrated in H1299 cells and used in all experiments described here.  
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Sequencing of Senecavirus A. The complete genome sequence of SVA isolate SD15-26 
was determined using the Illumina MiSeq sequencing platform. Prior to viral RNA 
extraction, 0.5 mL of the virus suspension was subjected to DNAse (10 U; Turbo DNAse, 
Ambion) and 5’ – phosphate-dependent exonuclease (Terminator™ 5’- Phosphate- 
Dependent Exonuclease; Epicentre) treatment for 30 min at 37°C. Viral RNA was purified 
using the QiaAmp viral RNA mini kit (Qiagen, Valencia, CA). First strand SVA cDNA 
was synthesized using the Protoscript II reverse transcriptase kit (New England Biolabs) 
and a pool of 10 SVA-specific primers targeting the entire viral genome (sequences 
available upon request). Second strand SVA cDNA was synthesized using the NEBNext 
mRNA second strand synthesis molecule (New England Biolabs) and purified using the 
Agencourt AMPure XP beads (Beckman Coulter, Brea, CA) according to the 
manufacturer’s protocols. One ng of double-stranded cDNA was used for DNA library 
preparation using the Nextera XT DNA library kit (Illimina, San Diego, CA) according to 
the manufacturer’s instructions. Following DNA library preparation, the sample was 
subjected to DNA sequencing using the Illumina MiSeq platform at the SD ADRDL. SVA 
genome was assembled using Ray v2.3.1 (Boisvert et al., 2012). Variants were assembled 
with Vicuna v1.3 (Yang et al., 2012) and Trinity r2011-11-26 (Grabherr et al., 2011). All 
variants were mapped with Consed v29 (Gordon & Green, 2013), samtools pileup (Li, 
2011) and VarScan.v2.4.1 (Koboldt et al., 2012) and aligned with the CLUSTALW  2.1 
multiple sequence alignment program (Thompson et al., 1994). 
Replication kinetics. Replication properties of SVA isolate SD15-26 was assessed in 
vitro. H1299 and PK-15 cells were cultured in 6-well plates, inoculated with SVA SD15-
26 at a multiplicity of infection MOI = 0.1, (multi-step growth curve); or MOI = 10, (single-
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step growth curve), and harvested at various time points post-infection (2, 4, 6, 8, 12, 24, 
36, and 48 h post-infection). Virus titers were determined on each time point using the 
Spearman and Karber’s method and TCID50/mL.  
Pathogenesis studies in pigs. The pathogenesis of SVA was evaluated in 4-months-old 
finishing pigs. Two experiments were conducted to assess SVA pathogenesis, clinical 
course of disease, patterns of virus shedding and virus load and tissue distribution. On the 
first experiment twelve commercial SVA negative finishing pigs (~55 kg were randomly 
allocated into two experimental groups as follows: Group 1, control group (RPMI 1640; n 
= 4) and Group 2, SVA inoculated group (SVA SD15-26; n = 8). Animals from Group 2 
were inoculated with 5 mL of a virus suspension containing 108.07 TCID50/mL via the oral 
(2 mL) and intranasal (1.5 mL on each nostril) (oronasal) routes. Animals from the control 
Group 1 were inoculated with RPMI 1640 medium in the same fashion. All animals were 
challenged on the day of arrival and Group 1 and Group 2 pigs were kept in individual 
rooms and received food and water ad libitum.  
Animals were monitored daily for clinical signs and lesions. Rectal temperatures 
were measured daily during 21 days. Oral, nasal, and rectal swabs and blood samples were 
collected on days 1, 3, 5, 7, 10, 14, 21, 28, 35, 38 pi. Dacron-tipped swabs were used for 
sample collection and placed in tubes containing 1 mL PBS. Blood samples were collected 
by jugular venipuncture and serum samples aliquoted and stored at -20°C until further 
processed. All animals from Group 2 were humanely euthanized on day 38 pi. Tissues 
including tonsil, heart, lung, mediastinal lymph node, liver, spleen, mesenteric lymph node, 
small intestine and large intestine were collected and half was frozen and processed for 
RT-qPCR and virus isolation while other half was fixed in 10% formalin and processed for 
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histological examinations and ISH. ISH was performed at the Veterinary Diagnostic 
Laboratory of the University of Minnesota as previously described (Resende et al., 2016). 
 To assess SVA tissue distribution and viral load during the acute phase of the 
infections, the four control animals from Group 1 were inoculated with SVA as above on 
day 35. Animals were monitored daily for clinical signs and lesions. One animal was 
humanely euthanized on day 3, 4, 5, and 6 pi and tissues including tonsil, heart, lung, 
mediastinal lymph node, liver, spleen, mesenteric lymph node, small intestine and large 
intestine were collected and processed as above. A fifth animal from Experiment 1 (no. 46) 
that died of unrelated cause on day 7 pi was included in this study. All experiments were 
conducted at SDSU Animal Resource Wing (ARW) and followed the protocols and 
guidelines approved by the SDSU Institutional Animal Care and Use Committee (approval 
number 16002A).  
Viral RNA extraction and real-time PCR (RT-qPCR). Viral nucleic acid was extracted 
from swab samples and tissues using the MagMAX viral RNA/DNA isolation kit (Life 
Technologies, Carlsbad, CA) following manufacturer’s instructions. Detection of SVA 
RNA was performed by using commercial RT-qPCR kit targeting the SVA 3D polymerase 
gene (EZ-SVA; Tetracore Inc., Rockville, MD). All RT-qPCR screenings were performed 
at the SDSU Animal Disease Research and Diagnostic Laboratory (ADRDL).   
Titrations and virus isolation (VI). The amount of SVA present in RT-qPCR positive 
samples was assessed by TCID50 and viral titers were determined according to the 
Spearman and Karber’s method. Samples were subjected to 10-fold serial dilutions (10-1 to 
10-6) and 100 µl of each dilution inoculated into H1299 cells cultured in 96-well plates (4 
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replicate wells/dilution). Cells were incubated at 37°C with 5% CO2 for 48 h, fixed with 
3.7% formaldehyde for 20 min and stained with a SVA whole virus rabbit polyclonal 
antibody followed by incubation with a secondary anti-rabbit IgG conjugated with Alexa 
594 (Thermo Fisher Scientific, Waltham, MA). Samples that were negative on the titrations 
were subjected to virus isolation in H1299 cells as previously described [25]. 
Virus Neutralization assay.  Neutralizing antibody responses elicited by SVA-infection 
were assessed using a virus neutralization assay. Serial 2-fold dilutions of serum (1:40 to 
1:2560) were incubated with 200 TCID50 of SVA SD15-26 for 1 h at 37°C. H1299 cells 
were added to each well (~0.2 x 105 cells/well) and plates incubated at 37°C for 48 hours. 
After incubation cells were fixed with 3.7% formaldehyde for 20 min and stained with an 
anti-SVA rabbit polyclonal antibody followed by incubation with the secondary anti-rabbit 
IgG conjugated with Alexa 594 (Thermo Fisher Scientific, Waltham, MA). VNs were read 
under a fluorescence microscope and NA titers were expressed as the reciprocal of the 
highest dilution of serum capable of completely inhibiting SVA infection/replication. 
Negative and positive control serum were included in all assays.  All samples were tested 
in triplicate independently and the average titer is presented.  
Immunofluorescence assay. Antibody responses elicited by SVA infection were 
evaluated by indirect immunofluorescence assay. To assess the levels of anti-SVA 
antibodies, H1299 cells were cultured in 96-well plates and infected with 200 TCID50 of 
SVA strain SD15-26. Cells were fixed at 48 hpi with 3.7% formaldehyde, permeabilized 
with 0.2% Triton X-100 and incubated with 2-fold serial dilutions of serum (1:40 to 
1:2560) for 1 h at 37°C. Cells were washed three times with PBS, incubated with a FITC 
conjugated anti-Swine IgG secondary antibody (Bethyl Laboratories, Montgomery, TX) 
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and evaluated under the fluorescence microscope. Antibody titers were determined as the 
reciprocal of the highest dilution of serum where SVA infected cells were observed. 
Negative and positive control samples were included in all assay plates. All samples were 
tested against infected and uninfected controls cell simultaneously.  
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Table 5 – Virus shedding by SVA SD15-26 infected animals detected by RT-qPCR. 
 
aOral secretions. 
bNasal secretions. 
cFeces. 
dNo SVA RNA detected by RT-qPCR.  
e SVA RNA detected by RT-qPCR 
NA: not available.  
 
 
 
 
 
Group   Virus shedding at days post-infection (pi) 
  1   3  5  7  10  14  21  28  35 
 Animal 
no. 
Oa Nb Fc  O N F  O N F  O N F  O N F  O N F  O N F  O N F  O N F 
Control 35 -d - -  - - -  - - -  - - -  - - -  - - -  - - -  - - -  - - - 
 36 - - -  - - -  - - -  - - -  - - -  - - -  - - -  - - -  - - - 
 37 - - -  - - -  - - -  - - -  - - -  - - -  - - -  - - -  - - - 
 38 - - -  - - -  - - -  - - -  - - -  - - -  - - -  - - -  - - - 
                                     
SVA  39 + + +  + + +  + + +  + + +  + + +  + + +  + + -  - - -  - - - 
 40 + + -  + + +  + + +  + + +  + + +  + + +  + + -  + - -  - - - 
 41 + + +  + + +  + + +  + + +  + + +  + + +  + + +  - - -  - - - 
 42 + + -  + + +  + + +  + + +  + + +  + + +  - - +  - - +  - - - 
 43 + + +  + + +  + + +  + + +  + + +  + + +  + + -  - - +  NA NA NA 
 44 + + -  + + +  + + +  + + +  + + +  + + -  + - +  - - -  - - - 
 45 + + +  + + +  + + +  + + +  + + +  + + +  + + -  - + -  - - - 
 46 + + +  + + +  + + +  + + +  NA NA NA  NA NA NA  NA NA NA  NA NA NA  NA NA NA 
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Table 6 – Virus shedding by SVA infected animals detected by virus isolation. 
aOral secretions. 
bNasal secretions. 
cFeces.  
dNegative sample after inoculation in cell cultures. 
ePositive sample after inoculation in cell cultures. 
NT: not tested. SVA was not detected by RT-qPCR. 
NA: not available. 
 
 
 
 
 
 
 
 
 
 
 
 
 
DPI  1  3 5 7 10 14 21 28 35 
Group  Animal 
no. 
Oa Nb Fc O N F O N F O N F O N F O N F O N F O N F O N F 
SVA  39 + +e + + + + + + + + - + + - - - - - + - NT NT NT NT NT NT NT 
 40 + + - + + + - + + + - + + - - - - - - - NT - NT NT NT NT NT 
 41 + + - + + + - - + + + + + - + - - - + - - NT NT NT NT NT NT 
 42 + + - + + + - + + + + - + - - - - - NT NT - NT NT NT NA NA NA 
 43 + + + + + + - + + + - - - - - - - NT + - NT NT NT - NT NT NT 
 44 + - - + - - - - - + - - - - - - - - + NT - NT NT - NT NT NT 
 45 + + + + + + + + - + + + - - - - - - + - NT NT - NT NT NT NT 
 46 - d + - + + + + + + + - + NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
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Table 7 – Tissue distribution of SVA during the acute stage of infection. 
 
aMediastinal lymph node. 
bMesenteric lymph node. 
cPositive sample. 
dNegative sample.  
N: Not tested. No SVA detected by RT-qPCR. 
                           Tissues 
 Lung Med. LNa Heart Liver Spleen Mes. LNb Small 
Intestine 
Large 
Intestine 
Kidney Tonsil 
Animal no. 
(dpi) 
RT-
qPCR 
VI RT-
qPCR 
VI RT-
qPCR 
VI RT-
qPCR 
VI RT-
qPCR 
VI RT-
qPCR 
VI RT-
qPCR 
VI RT-
qPCR 
VI RT-
qPCR 
VI RT-
qPCR 
VI 
35 (3 dpi) +c + + + - N + + + + + + + + + + - N + + 
36 (4 dpi) + + + + + - + + + + + + + + + + + + + + 
38 (5 dpi) + -d + + - N + - + + + + + - + + - N + + 
37 (6 dpi) + - + - + - + - + - + - + - + - + - + - 
46 (7 dpi) + - + - + - + - + - + - + - + - - N + + 
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Fig 5. Senecavirus A-induced vesicular disease in swine. (a) Progression of SVA-induced 
vesicular disease in swine. Animals were inoculated with SVA strain SD15-26 via the 
oronasal route. Vesicular lesions on the snout were first observed on day 4 pi and by day 6 
pi vesicles ruptured leaving an eroded/ulcered lesion on the skin which progressed leaving 
a crust covering the affected area (days 8-9 pi). By day 11 pi only a small scar remained 
on the snout and by day 15 pi the lesion was completely resolved. (b) Distinct lesions 
observed in SVA-infected pigs. While some animals presented erythema or small vesicles 
on the snout (top panels) other animals presented large vesicles on the snout or feet, located 
in the interdigital space, dewclaws and/or coronary band (bottom panels; yellow arrows). 
(c) In situ hybridization demonstrating the presence of SVA RNA (pink color) in the skin 
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of the coronary band of SVA-infected swine. Staining was observed in keratinocytes in 
intraepidermal vesicles in stratus spinosum and stratus basale (day 4 pi). 
 
 
Fig 6. Infection dynamics of SVA in swine. (a) Viremia detected in serum by RT-qPCR 
and expressed as log10 genome copy number per mL. Error bars represent standard error 
of the mean (SEM). (b) Virus shedding in nasal and oral secretions and in feces of SVA-
infected animals. Levels of virus shedding were determined by RT-qPCR and expressed as 
log10 genome copy numbers per mL. Error bars represent standard error of the mean 
(SEM). No viremia or virus shedding were detected in control non-infected animals. 
 
 
 
65 
 
 
 
 
Fig 7. Viral load and tissue distribution of SVA during infection in finishing pigs. (a) Viral 
load in different tissues collected between days 3 and 7 post-infection. Levels of SVA were 
determined by RT-qPCR and expressed as log10 genome copy number per mL. (b) In situ 
hybridization demonstrating the presence of SVA nucleic acid (pink color) in the tonsil of 
SVA-infected pigs on days 3 (no. 35) and 4 pi (no. 36). Multifocal staining was observed 
in crypt epithelium and sub-epithelial lymphocytes. (c) Viral load in different tissues 
collected on day 38 post-infection. Levels of SVA were determined by RT-qPCR and 
expressed as log10 genome copy number per mL. (d) In situ hybridization demonstrating 
the presence of SVA nucleic acid (pink color) in the tonsil of SVA-infected pigs on days 
28 (no. 43) and 38 pi (no. 40). Multifocal staining was observed in crypt epithelium, sub-
epithelial lymphocytes and lymphoid follicles 
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Fig 8. Histological changes observed in SVA-infected swine. (a) Histological sections of 
the skin recovering the coronary band of an animal that presented vesicular lesion after 
SVA-infection (day 4 pi). Lesions were characterized by perivascular inflammation with 
separation of the epidermis from the dermis and accumulation of fibrin, edema, 
hemorrhage and inflammatory cells within the cleft (top panels; 100X [left]; 200 X [right]). 
Bottom panels show intense inflammation and separation at the dermal-epidermal junction 
with accumulation of inflammatory exudate and necrotic keratinocytes (100X [left]; 400X 
[right]). (b) Histological section of the tonsil of a SVA-infected animal (day 4 pi). 
Histological changes in the tonsil were characterized by lymphoid hyperplasia (left panel). 
In situ hybridization demonstrating the presence of SVA nucleic acid (pink color) in 
lymphoid follicles (right panel) 
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. 
Fig 9. Serological responses to Senecavirus A. (a) Indirect immunofluorescence assay 
demonstrating serum IgG antibody responses against SVA.  (b) Virus neutralization assay 
demonstrating neutralizing antibody responses against SVA. Red diamonds represent 
individual control uninfected animals. Blue dots represent individual SVA-infected 
animals. Error bars represent the standard error of the mean (SEM). 
 
CONCLUSION 
The overall goal of this study was to understand the epidemiology and pathogenesis of 
Senecavirus A (SVA). Below are the conclusions from our studies: 
1. Contemporary SVA strains that emerged in 2014-2015 have significantly diverged 
from historical strains, circulating in the US since late 1980’s. 
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2. Detection of SVA in mice and houseflies and its isolation from mice suggest that 
these pests could play role in SVA transmission. Therefore, these pests should be 
considered while devising control programs for SVA. 
3. SVA induces an acute self-limiting vesicular disease in pigs. Lesions are first 
observed after a short incubation period around days 3-4 post-inoculation. 
4. SVA infected animals shed virus through oral, and nasal secretions and feces. 
Viable virus can be detected in oral fluid up to day 21 post-infection. 
5. Neutralizing antibodies are produced by day 5 post-infection and animals usually 
recover in 2-3 weeks. 
6. Viral RNA can be detected in multiple tissues of the infected animal. Lymphoid 
tissues, in particular, the tonsil seems to serve as a primary site of SVA replication. 
Our studies confirm the role of SVA as the etiologic agent of vesicular disease in 
pigs and further provide significant insights about the pathogenesis and infection 
dynamic of this important virus of swine.  
 
Fig 10. Infection dynamics of SVA in pigs 
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